The synthesis of dihydrotestosterone is catalyzed by steroid 5 alpha-reductase isozymes, designated types 1 and 2. Mutation of type 2 results in male pseudohermaphroditism, in which the external genitalia are phenotypically female at birth. Two striking and unexplained features of this disorder are that external genitalia of affected males undergo virilization during puberty and that these individuals have less temporal hair regression. The tissue-specific and developmental expression patterns of the 5 alpha-reductase isozymes were investigated by immunoblotting. The type 1 isozyme is not detectable in the fetus, is transiently expressed in newborn skin and scalp, and permanently expressed in skin from the time of puberty. There was no qualitative difference in 5 alpha-reductase type 1 expression between adult balding vs. nonbalding scalp. The type 2 isozyme is transiently expressed in skin and scalp of newborns. Type 2 is the predominant isozyme detectable in fetal genital skin, male accessory sex glands, and in the prostate, including benign prostatic hyperplasia and prostate adenocarcinoma tissues. Both isozymes are expressed in the liver, but only after birth. These results are consistent with 5 alpha-reductase type 1 being responsible for virilization in type 2-deficient subjects during puberty, and suggest that the type 2 isozyme may be an initiating factor in development of male pattern baldness.
A E Thigpen, R I Silver, J M Guileyardo, M L Casey, J D McConnell, D W Russell
Title and authors | Publication | Year |
---|---|---|
Aberrant Expression Levels of Androgen Receptor and SRD5A2 in Epididymal Epithelial Cells of Crossbred Infertile Cattle–Yak
Wittayarat M, Kawanishi K, Ohata H, Nagahara M, Sambuu R, Sambuu O, Hirata M, Tanihara F, Taniguchi M, Otoi T, Sato Y |
Animals : an Open Access Journal from MDPI | 2025 |
3,5-Disubstituted pyrazoline as a promising core for anticancer agents: mechanisms of action and therapeutic potentials
Gabr BS, Shalabi AR, Said MF, George RF |
Future Medicinal Chemistry | 2025 |
The 100 most cited articles in androgenetic alopecia: A bibliometric analysis
Sawar K, Mekani L, Kallabat A, Kato D, Potts GA |
Medicine | 2025 |
Finasteride delays atherosclerosis progression in mice and is associated with a reduction in plasma cholesterol in men
McQueen P, Molina D, Pinos I, Krug S, Taylor AJ, LaFrano MR, Kane MA, Amengual J |
Journal of lipid research | 2024 |
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease.
Polyzos SA, Targher G |
Current Obesity Reports | 2024 |
Identification and characterization of dystrophin-locus-derived testis-specific protein: A testis-specific gene within the intronic region of the rat dystrophin gene
YAMANOUCHI K, KATO S, TANAKA Y, IKEDA M, OSHIMO Y, SHIGA T, HATAMOTO K, CHAMBERS J, IMAMURA T, HIRAMATSU R, UCHIDA K, MATSUDA F, MATSUWAKI T, KOHSAKA T |
Journal of Reproduction and Development | 2024 |
Current Understanding of Androgen Signaling in Prostatitis and its Treatment: A Review.
Cabeza M |
Current medicinal chemistry | 2024 |
The Etiology and Pathogenesis of Benign Prostatic Hyperplasia: The Roles of Sex Hormones and Anatomy
Xu G, Dai G, Huang Z, Guan Q, Du C, Xu X |
Research and Reports in Urology | 2024 |
Is There an Association between 5a Reductase Inhibitors and Metabolic Syndrome? A Narrative Review of the Literature.
Ziogou A, Giannakodimos A, Mitakidi E, Konstantinos T, Giannakodimos I |
Reviews on recent clinical trials | 2024 |
Steroid metabolism and hormonal dynamics in normal and malignant ovaries
Beevors LI, Sundar S, Foster PA |
Essays in Biochemistry | 2024 |
Sinomenine Hydrochloride Can Ameliorate Benign Prostatic Hyperplasia by Lowering the 5α-Reductase 2 Level and Regulating the Balance between the Proliferation and Apoptosis of Cells.
Fan MS, Xia YF, Ye RH, Sun ZR, Wang MY, An MF, Zhang SS, Zhang LJ, Zhao YL, Xiang ZM, Sheng J |
Molecules (Basel, Switzerland) | 2023 |
Insights in the maturational processes influencing hydrocortisone pharmacokinetics in congenital adrenal hyperplasia patients using a middle-out approach.
Michelet R, Bindellini D, Melin J, Neumann U, Blankenstein O, Huisinga W, Johnson TN, Whitaker MJ, Ross R, Kloft C |
Frontiers in pharmacology | 2023 |
The Comprehensive Steroidome in Complete TSPO/PBR Knockout Mice under Basal Conditions.
Liere P, Liu GJ, Pianos A, Middleton RJ, Banati RB, Akwa Y |
International journal of molecular sciences | 2023 |
Ultrasound-induced cavitation renders prostate cancer cells susceptible to hyperthermia: Analysis of potential cellular and molecular mechanisms.
Hu S, Zhang X, Melzer A, Landgraf L |
Frontiers in Genetics | 2023 |
Targeting sex steroid biosynthesis for breast and prostate cancer therapy.
Poutanen M, Hagberg Thulin M, Härkönen P |
Nature reviews. Cancer | 2023 |
Two genetic variants in the SRD5A2 gene are found to be associated with sex differences in the disease characteristics of patients with chronic hepatitis B virus infection.
Duan H, Wang X, Qi W, Shi J, Han L, Wang G, Xu Y, Liu J, Wang J |
Biology of sex differences | 2023 |
Histological analysis of testes in patients with 5 alpha-reductase deficiency type 2: Comparison with cryptorchid testes in patients without endocrinological abnormalities and a review of the literature.
Wada T, Ichikawa C, Takeuchi M, Matsui F, Matsumoto F, Ida S, Etani Y, Kawai M |
2022 | |
Expression of CSF1, AR, and SRD5A2 during Postnatal Development of the Boar Reproductive Tract.
Katleba K, Legacki E, Berger T |
2022 | |
Overexpression of SRD5A3 in Hepatocellular Carcinoma and Its Molecular Mechanism: A Study of Bioinformatics Exploration Analysis with Experimental Verification.
Chen E, Yi J, Ren Q, Mi Y, Gan Z, Liu J |
Evidence-based complementary and alternative medicine : eCAM | 2022 |
In vivo delivery of CRISPR-Cas9 genome editing components for therapeutic applications
Huang K, Zapata D, Tang Y, Teng Y, Li Y |
Biomaterials | 2022 |
The 5α-reductase inhibitor finasteride reduces opioid self-administration in animal models of opioid use disorder
Gabriel D. Bosse, Roberto Cadeddu, Gabriele Floris, Ryan D Farero, Eva Vigato, Suhjung Janet Lee, Tejia Zhang, Nilesh Gaikwad, Kristen Keefe, Paul Phillips, Marco Bortolato, Randall T. Peterson |
Journal of Clinical Investigation | 2021 |
Highlights on Steroidal Arylidene Derivatives as a Source of Pharmacologically Active Compounds: A Review
V Brito, G Alves, P Almeida, S Silvestre |
Molecules (Basel, Switzerland) | 2021 |
Suppression of steroid 5α-reductase type I promotes cellular apoptosis and autophagy via PI3K/Akt/mTOR pathway in multiple myeloma
R Dou, J Qian, W Wu, Y Zhang, Y Yuan, M Guo, R Wei, S Yang, A Jurczyszyn, S Janz, M Beksac, C Gu, Y Yang |
Cell Death and Disease | 2021 |
Cell culture as a toolbox to generate phase I metabolites for antidoping screening
R Savill, H Baues, E Voigt, O Zierau, D Thieme, AM Keiler |
Drug Testing and Analysis | 2021 |
5α‐reductase inhibitors: Evaluation of their potential confounding effect on GC‐C‐IRMS doping analysis
L Iannella, C Colamonici, D Curcio, F Botrè, X Torre |
Drug Testing and Analysis | 2021 |
The role of 5-reduction in physiology and metabolic disease: evidence from cellular, pre-clinical and human studies
N Nikolaou, L Hodson, JW Tomlinson |
The Journal of Steroid Biochemistry and Molecular Biology | 2021 |
Managing patterned hair loss – a hair raising task!
A Sharma, M Shirolikar, M Mhatre |
2021 | |
The association of new-onset diabetes mellitus and medical therapy for benign prostatic hyperplasia: A population-based study.
Johnstone J, Lusty A, Tohidi M, Whitehead M, Tranmer J, Nickel JC, Siemens DR |
Canadian Urological Association journal = Journal de l'Association des urologues du Canada | 2021 |
Dihydrotestosterone Induces Proliferation, Migration, and Invasion of Human Glioblastoma Cell Lines DC Rodríguez-Lozano, DE Velázquez-Vázquez, AD Moral-Morales, I Camacho-Arroyo |
OncoTargets and therapy | 2020 |
Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
J Robitaille, VS Langlois |
General and Comparative Endocrinology | 2020 |
The therapeutic effects of Stauntonia hexaphylla in benign prostate hyperplasia are mediated by the regulation of androgen receptors and 5α-reductase type 2
GL Hong, SR Park, DY Jung, S Karunasagara, KP Lee, EJ Koh, K Cho, SS Park, JY Jung |
Journal of Ethnopharmacology | 2020 |
Steroid 5 alpha-reductase 3 (SRD5A3) promotes tumor growth and predicts poor survival of human hepatocellular carcinoma (HCC)
Q Mai, D Sheng, C Chen, Q Gou, M Chen, X Huang, H Yin, X Chen, Z Chen |
Aging | 2020 |
Genetic Analysis of 25 Patients with 5 α -Reductase Deficiency in Chinese Population
B Han, T Cheng, H Zhu, J Yu, W Zhu, H Song, H Yao, J Qiao |
BioMed Research International | 2020 |
The Role of Androgen Signaling in Male Sexual Development at Puberty
RA Rey |
Endocrinology | 2020 |
Meta-Analysis of steroid-converting enzymes and related receptors in prostate cancer suggesting novel combined therapies
WF Zhang, T Li, SX Lin |
The Journal of Steroid Biochemistry and Molecular Biology | 2020 |
Expression in Escherichia Coli, Purification, and Functional Reconstitution of Human Steroid 5α-Reductases
HM Peng, J Valentín-Goyco, SC Im, B Han, J Liu, J Qiao, RJ Auchus |
Endocrinology | 2020 |
Progesterone in the Brain: Hormone, Neurosteroid and Neuroprotectant
R Guennoun |
International journal of molecular sciences | 2020 |
A Mechanism by which Ergosterol Inhibits the Promotion of Bladder Carcinogenesis in Rats
N Ikarashi, M Hoshino, T Ono, T Toda, Y Yazawa, K Sugiyama |
Biomedicines | 2020 |
Ultrasound-activated particles as CRISPR/Cas9 delivery system for androgenic alopecia therapy
JY Ryu, EJ Won, HA Lee, JH Kim, E Hui, HP Kim, TJ Yoon |
Biomaterials | 2020 |
Protective Role of Nutritional Plants Containing Flavonoids in Hair Follicle Disruption: A Review
E Bassino, F Gasparri, L Munaron |
International journal of molecular sciences | 2020 |
Transcriptomic analysis reveals the key regulators and molecular mechanisms underlying myometrial activation during equine placentitis†
HE Ali, YL Boakari, SC Loux, P Dini, KE Scoggin, A Esteller-Vico, T Kalbfleisch, BA Ball |
Biology of reproduction | 2020 |
Clinical characteristics and genotype‐phenotype correlations of 130 Chinese children in a high‐homogeneity single‐center cohort with 5α‐reductase 2 deficiency
L Fan, Y Song, M Polak, L Li, X Ren, B Zhang, D Wu, C Gong |
Molecular Genetics & Genomic Medicine | 2020 |
Pharmacological treatment of lower urinary tract symptoms in benign prostatic hyperplasia: consequences on sexual function and possible endocrine effects
SL Vignera, A Aversa, R Cannarella, RA Condorelli, Y Duca, GI Russo, AE Calogero |
Expert Opinion on Pharmacotherapy | 2020 |
Jean Wilson and his legacy, 50 years and counting
AP Kenigsberg, WD Tilley, GV Raj |
Urology | 2020 |
Advances in Knowledge of Androgens: How Intentional and Accidental Neurosteroid Changes Inform Us of Their Action and Role
CA Frye, D DaCosta, VF Lembo, AA Walf |
Current Sexual Health Reports | 2020 |
Association between 5α-reductase inhibitors therapy and incidence, cancer-specific mortality, and progression of prostate cancer: evidence from a meta-analysis
LM Luo, RD Yang, JM Wang, SK Zhao, YZ Liu, ZG Zhu, Q Xiang, ZG Zhao |
Asian Journal of Andrology | 2020 |
Alternative pathway androgen biosynthesis and human fetal female virilization
N Reisch, AE Taylor, EF Nogueira, DJ Asby, V Dhir, A Berry, N Krone, RJ Auchus, CH Shackleton, NA Hanley, W Arlt |
Proceedings of the National Academy of Sciences | 2019 |
Liver and Steroid Hormones—Can a Touch of p53 Make a Difference?
M Charni-Natan, R Aloni-Grinstein, E Osher, V Rotter |
Frontiers in Endocrinology | 2019 |
Growth Pattern in Chinese Children With 5α-Reductase Type 2 Deficiency: A Retrospective Multicenter Study
X Zhao, Y Song, S Chen, X Wang, F Luo, Y Yang, L Chen, R Chen, H Chen, Z Su, D Wu, C Gong |
Frontiers in pharmacology | 2019 |
Testosterone May Hold Therapeutic Promise for the Treatment ofIschemic Stroke in Aging: A Closer Look at Laboratory Findings
F Farajdokht, M Farhoudi, A Majdi, M Zamanlu, S Sadigh-Eteghad, S Vahedi, J Mahmoudi |
Advanced pharmaceutical bulletin | 2019 |
Finasteride and androgenic alopecia; from therapeutic options to medical implications
IG Motofei, DL Rowland, M Tampa, MI Sarbu, MI Mitran, CI Mitran, AP Stoian, CC Diaconu, S Paunica, SR Georgescu |
Journal of Dermatological Treatment | 2019 |
Deciphering the binding of dutasteride with human alpha-2-macroglobulin: Molecular docking and calorimetric approach
MK Zia, T Siddiqui, SS Ali, H Ahsan, FH Khan |
International Journal of Biological Macromolecules | 2019 |
The efficacy and use of finasteride in women: a systematic review
AC Hu, LW Chapman, NA Mesinkovska |
International Journal of Dermatology | 2019 |
In silico and functional studies reveal novel loss-of-function variants of SRD5A2, but no variants explaining excess 5α-reductase activity
E Katharopoulos, K Sauter, AV Pandey, CE Flück |
The Journal of Steroid Biochemistry and Molecular Biology | 2019 |
Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: A comprehensive review
L Schiffer, L Barnard, ES Baranowski, LC Gilligan, AE Taylor, W Arlt, CH Shackleton, KH Storbeck |
The Journal of Steroid Biochemistry and Molecular Biology | 2019 |
Early embryonic exposure of freshwater gastropods to pharmaceutical 5-alpha-reductase inhibitors results in a surprising open-coiled “banana-shaped” shell
A Baynes, GM Pino, GH Duong, AE Lockyer, C McDougall, S Jobling, EJ Routledge |
Scientific Reports | 2019 |
In Vivo Effects of Polymerized Anthocyanin from Grape Skin on Benign Prostatic Hyperplasia
YJ Choi, M Fan, Y Tang, HP Yang, JY Hwang, EK Kim |
Nutrients | 2019 |
The diagnosis of androgenetic alopecia in children: Considerations of pathophysiological plausibility
A Rossi, A D'Arino, F Pigliacelli, G Caro, M Muscianese, MC Fortuna, M Carlesimo |
Australasian Journal of Dermatology | 2019 |
Topical Antiandrogen Therapies for Androgenetic Alopecia and Acne Vulgaris
DH Marks, S Prasad, BD Souza, LJ Burns, MM Senna |
American Journal of Clinical Dermatology | 2019 |
New insights into 5α-reductase type 2 deficiency based on a multi-centre study: regional distribution and genotype–phenotype profiling of SRD5A2 in 190 Chinese patients
B Gui, Y Song, Z Su, FH Luo, L Chen, X Wang, R Chen, Y Yang, J Wang, X Zhao, L Fan, X Liu, Y Wang, S Chen, C Gong |
Journal of medical genetics | 2019 |
Detection of testosterone doping in female athletes
DJ Handelsman, S Bermon |
Drug Testing and Analysis | 2019 |
Identification of three novel SRD5A2 mutations in Chinese patients with 5α-reductase 2 deficiency
T Cheng, H Wang, B Han, H Zhu, HJ Yao, SX Zhao, WJ Zhu, HL Zhai, FG Chen, HD Song, KX Cheng, Y Liu, J Qiao |
Asian Journal of Andrology | 2019 |
Intracrine androgen biosynthesis, metabolism and action revisited
L Schiffer, W Arlt, KH Storbeck |
Molecular and Cellular Endocrinology | 2018 |
The impact of androgen actions in neurons on metabolic health and disease
JJ Morford, S Wu, F Mauvais-Jarvis |
Molecular and Cellular Endocrinology | 2018 |
Berberine Improves Benign Prostatic Hyperplasia via Suppression of 5 Alpha Reductase and Extracellular Signal-Regulated Kinase in Vivo and in Vitro
DH Youn, J Park, HL Kim, Y Jung, JW Kang, S Lim, G Song, HJ Kwak, JY Um |
Frontiers in pharmacology | 2018 |
Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviors
LJ Mosher, SC Godar, M Morissette, KM McFarlin, S Scheggi, C Gambarana, SC Fowler, TD Paolo, M Bortolato |
Psychoneuroendocrinology | 2018 |
Impact of anabolic androgenic steroids on sexual function
JM Armstrong, RA Avant, CM Charchenko, ME Westerman, MJ Ziegelmann, TS Miest, LW Trost |
Translational andrology and urology | 2018 |
The new paradigm for androgenetic alopecia and plant-based folk remedies: 5α-reductase inhibition, reversal of secondary microinflammation and improving insulin resistance
NJ Sadgrove |
Journal of Ethnopharmacology | 2018 |
Molecular genetics and phenotype/genotype correlation of 5-α reductase deficiency in a highly consanguineous population
MM Alswailem, OS Alzahrani, L Alghofaili, E Qasem, M Almohanaa, A Alsagheir, BB Abbas, NA Attia, AA Shaikh, AS Alzahrani |
Endocrine | 2018 |
Seasonal expression of 5α-reductases and androgen receptor in the prostate gland of the wild ground squirrel ( Spermophilus dauricus )
Y Zhang, Y Wang, C Huang, Y Wang, H Qi, Y Han, Z Yuan, Q Weng, H Zhang |
Comparative biochemistry and physiology. Part A, Molecular & integrative physiology | 2018 |
Alopecia androgenetica der Frau
G Lutz |
gynäkologie + geburtshilfe | 2018 |
5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis
J Wang, S Zhao, L Luo, E Li, X Li, ZG Zhao |
International braz j urol | 2018 |
Effects of the Korean Medicinal Herbs for Treatment of Benign Prostatic Hyperplasia Induced in Rat Models: A Review
I Bae, S Jung |
The Journal of Internal Korean Medicine | 2018 |
Drugs for benign prostatic hypertrophy.
Jiwrajka M, Yaxley W, Ranasinghe S, Perera M, Roberts MJ, Yaxley J |
Australian Prescriber | 2018 |
Androgenetic alopecia: a review
F Lolli, F Pallotti, A Rossi, MC Fortuna, G Caro, A Lenzi, A Sansone, F Lombardo |
Endocrine | 2017 |
Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers
CK Zhou, FZ Stanczyk, M Hafi, CC Veneroso, B Lynch, RT Falk, S Niwa, E Emanuel, YT Gao, GP Hemstreet, L Zolfghari, PR Carroll, MJ Manyak, IA Sesterhenn, PH Levine, AW Hsing, MB Cook |
The Prostate | 2017 |
Anti-proliferative activities of finasteride in benign prostate epithelial cells require stromal fibroblasts and c-Jun gene
K Wang, S Jin, D Fan, M Wang, N Xing, Y Niu, HK Bid |
PloS one | 2017 |
Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride
T Kiguradze, WH Temps, PR Yarnold, J Cashy, RE Brannigan, B Nardone, G Micali, DP West, SM Belknap |
PeerJ | 2017 |
Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels
A Rył, I Rotter, A Grzywacz, I Małecka, K Skonieczna-Żydecka, K Grzesiak, M Słojewski, A Szylińska, O Sipak-Szmigiel, M Piasecka, K Walczakiewicz, M Laszczyńska |
International journal of environmental research and public health | 2017 |
Targeting phenotypic heterogeneity in benign prostatic hyperplasia
DW Strand, DN Costa, F Francis, WA Ricke, CG Roehrborn |
Differentiation; research in biological diversity | 2017 |
Association between SRD5A2 rs523349 and rs9282858 Polymorphisms and Risk of Benign Prostatic Hyperplasia: A Meta-Analysis
XT Zeng, XJ Su, S Li, H Weng, TZ Liu, XH Wang |
Frontiers in physiology | 2017 |
Sensitivity of doping biomarkers after administration of a single dose testosterone gel
J Mullen, A Börjesson, O Hopcraft, JJ Schulze, M Ericsson, A Rane, M Lehtihet, L Ekström |
Drug Testing and Analysis | 2017 |
Seasonal expression of P450c17 and 5α-reductase-2 in the scented gland of male muskrats ( Ondatra zibethicus )
W Han, W Xie, Y Zhang, F Zhang, H Zhang, Y Han, Z Yuan, Q Weng |
General and Comparative Endocrinology | 2017 |
Letter to the Editor: “Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss”
J Santmann |
The Journal of clinical endocrinology and metabolism | 2017 |
Finasteride-loaded biodegradable nanoparticles: Near-infrared quantification of plasma and prostate levels
OA Ahmed, UA Fahmy, AS Al-Ghamdi, BM Aljaeid, H Aldawsari, O Fahmy, HA Sarhan, MG Asri |
J BIOACT COMPAT POL | 2017 |
Antiandrogen withdrawal syndrome (AAWS) in the treatment of patients with prostate cancer
G Leone, M Tucci, C Buttigliero, C Zichi, D Pignataro, P Bironzo, F Vignani, GV Scagliotti, MD Maio |
Endocrine Related Cancer | 2017 |
Butylated hydroxyanisole alters rat 5α-reductase and 3α-hydroxysteroid dehydrogenase: Implications for influences of neurosteroidogenesis
J Guo, L Li, S Zhou, Y Su, X Li, J Sun, RS Ge |
Neuroscience Letters | 2017 |
Allopregnanolone levels and depressive symptoms during pregnancy in relation to single nucleotide polymorphisms in the allopregnanolone synthesis pathway
C Hellgren, E Comasco, A Skalkidou, I Sundström-Poromaa |
Hormones and Behavior | 2017 |
Molecular basis for prostate cancer racial disparities
Santosh K Singh, James W Lillard Jr, Rajesh Singh |
Frontiers in bioscience : a journal and virtual library | 2017 |
Dual-5α-Reductase Inhibition Promotes Hepatic Lipid Accumulation in Man
JM Hazlehurst, AI Oprescu, N Nikolaou, RD Guida, AE Grinbergs, NP Davies, RB Flintham, MJ Armstrong, AE Taylor, BA Hughes, J Yu, L Hodson, WB Dunn, JW Tomlinson |
The Journal of clinical endocrinology and metabolism | 2016 |
Endocrinology: Adult and Pediatric
M Gurnell, TJ Visser, P Beck-Peccoz, VK Chatterjee |
Endocrinology: Adult and Pediatric | 2016 |
Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase
HM Choi, Y Jung, J Park, HL Kim, DH Youn, JW Kang, MY Jeong, JH Lee, WM Yang, SG Lee, KS Ahn, JY Um |
Scientific Reports | 2016 |
Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials
LW Trost, JP Mulhall |
Journal of Sexual Medicine | 2016 |
The metabolic fate and receptor interaction of 16α-hydroxyprogesterone and its 5α-reduced metabolite, 16α-hydroxy-dihydroprogesterone
D Rooyen, T Toit, RL Toit, D Africander, P Swart, AC Swart |
Molecular and Cellular Endocrinology | 2016 |
Safety and Tolerability of the Dual 5-Alpha Reductase Inhibitor Dutasteride in the Treatment of Androgenetic Alopecia
GS Choi, JH Kim, SY Oh, JM Park, JS Hong, YS Lee, WS Lee |
Annals of Dermatology | 2016 |
Androgens modulate gene expression and specific DNA methylation pattern of steroid 5α-reductases in the frog Silurana tropicalis
S Bissegger, VS Langlois |
General and Comparative Endocrinology | 2016 |
Endocrinology
C Napier, SH Pearce |
Endocrinology | 2016 |
Upper-body resistance exercise augments vastus lateralis androgen receptor–DNA binding and canonical Wnt/β-catenin signaling compared to lower-body resistance exercise in resistance-trained men without an acute increase in serum testosterone
M Spillane, N Schwarz, DS Willoughby |
Steroids | 2015 |
Progesterone-induced stimulation of mammary tumorigenesis is due to the progesterone metabolite, 5α-dihydroprogesterone (5αP) and can be suppressed by the 5α-reductase inhibitor, finasteride
JP Wiebe, MA Rivas, MF Mercogliano, PV Elizalde, R Schillaci |
The Journal of Steroid Biochemistry and Molecular Biology | 2015 |
Generation of comparative pharmacophoric model for steroidal 5α-reductase I and II inhibitors: A 3D-QSAR study on 6-azasteroids
S Thareja, T Rajpoot, SK Verma |
Steroids | 2015 |
Hamster SRD5A3 lacks steroid 5α-reductase activity in vitro
B Chávez, L Ramos, R García-Becerra, F Vilchis |
Steroids | 2015 |
5α-Reductase inhibitors increase acute coronary syndrome risk in patients with benign prostate hyperplasia
CH Chou, CL Lin, MC Lin, FC Sung, CH Kao |
Journal of Endocrinological Investigation | 2015 |
Human sperm molecular anatomy: the enzyme 5α-reductase (SRD5A) is present in the sperm and may be involved in the varicocele-related infertility
S Aquila, D Montanaro, C Guido, M Santoro, I Perrotta, S Gervasi, FD Amicis, M Lanzino |
Histochemistry and Cell Biology | 2015 |
Phenotype and molecular characteristics in 45 Chinese children with 5α-reductase type 2 deficiency from South China
J Cheng, R Lin, W Zhang, G Liu, H Sheng, X Li, Z Zhou, X Mao, L Liu |
Clinical Endocrinology | 2015 |
Evaluation of bioequivalence of five 0.1 mg dutasteride capsules compared to one 0.5 mg dutasteride capsule: a randomized study in healthy male volunteers
MJ Fossler, DA Collins, H Ino, N Sarai, R Ravindranath, CL Bowen, O Burns |
Journal of Drug Assessment | 2015 |
Setting reference values in trichology
A Rebora, M Guarrera, F Drago, A Rossi, MC Fortuna, R D'Ovidio, P Chieco, BM Piraccini, M Starace |
International Journal of Dermatology | 2015 |
Risk of Fractures and Falls during and after 5-α Reductase Inhibitor Use: A Nationwide Cohort Study
D Robinson, H Garmo, P Stattin, K Michaëlsson, J Kim |
PloS one | 2015 |
Anti-proliferation effects of Cistanches salsa on the progression of benign prostatic hyperplasia
E Jeon, KS Chung, H An |
Canadian Journal of Physiology and Pharmacology | 2015 |
The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being
AM Traish |
Current Sexual Health Reports | 2015 |
Nutraceuticals and Functional Foods in Human Health and Disease Prevention
S Lee, T Vance, O Chun |
Nutraceuticals and Functional Foods in Human Health and Disease Prevention | 2015 |
Clinical profile of 93 cases of 46, XY disorders of sexual development in a referral center
BC Mota, LM Oliveira, R Lago, P Brito, AK Canguçú-Campinho, U Barroso, MB Toralles |
International braz j urol | 2015 |
The intriguing role of fibroblasts and c-Jun in the chemo-preventive and therapeutic effect of finasteride on xenograft models of prostate cancer
YN Niu, K Wang, S Jin, DD Fan, MS Wang, NZ Xing, SJ Xia |
Asian Journal of Andrology | 2015 |
Seasonal variation of urinary microRNA expression in male goats (Capra hircus) as assessed by next generation sequencing
KM Longpre, NS Kinstlinger, EA Mead, Y Wang, AP Thekkumthala, KA Carreno, A Hot, JM Keefer, L Tully, LS Katz, AZ Pietrzykowski |
General and Comparative Endocrinology | 2014 |
Genetic Steroid Disorders
DE Reichman, Z Rosenwaks |
Genetic Steroid Disorders | 2014 |
5α-reductase type I expression is downregulated in the prefrontal cortex/Brodmann’s area 9 (BA9) of depressed patients
RC Agis-Balboa, A Guidotti, G Pinna |
Psychopharmacology | 2014 |
Finasteride treatment alters tissue specific androgen receptor expression in prostate tissues: Finasteride Alters AR Expression
TM Bauman, PD Sehgal, KA Johnson, T Pier, RC Bruskewitz, WA Ricke, W Huang |
The Prostate | 2014 |
Differential expression of 5-alpha reductase isozymes in the prostate and its clinical implications
K Wang, DD Fan, S Jin, NZ Xing, YN Niu |
Asian Journal of Andrology | 2014 |
Androgens and prostate disease
LA Cooper, ST Page |
Asian Journal of Andrology | 2014 |
Cellular Endocrinology in Health and Disease
AA Bremer, WL Miller |
Cellular Endocrinology in Health and Disease | 2014 |
Relative adrenal insufficiency in mice deficient in 5α-reductase 1
DE Livingstone, EM di Rollo, C Yang, LE Codrington, JA Mathews, M Kara, KA Hughes, CJ Kenyon, BR Walker, R Andrew |
Journal of Endocrinology | 2014 |
Impact of Alpha Blockers, 5-alpha Reductase Inhibitors and Combination Therapy on Sexual Function
C Welliver, M Butcher, Y Potini, KT McVary |
Current Urology Reports | 2014 |
Gender Differences in Multiple Sclerosis: Induction of Estrogen Signaling in Male and Progesterone Signaling in Female Lesions
S Luchetti, CG van Eden, K Schuurman, ME van Strien, DF Swaab, I Huitinga |
Journal of Neuropathology and Experimental Neurology | 2014 |
GENDER-SPECIFIC ASSOCIATION OF VARIANTS IN THE AKR1C1 GENE WITH DIMENSIONAL ANXIETY IN PATIENTS WITH PANIC DISORDER: ADDITIONAL EVIDENCE FOR THE IMPORTANCE OF NEUROSTEROIDS IN ANXIETY?: Research Article: Association of AKR1C1 Variants with Anxiety
C Quast, A Reif, T Brückl, H Pfister, H Weber, M Mattheisen, S Cichon, T Lang, A Hamm, L Fehm, A Ströhle, V Arolt, K Domschke, T Kircher, HU Wittchen, P Pauli, AL Gerlach, GW Alpers, J Deckert, R Rupprecht, EB Binder, A Erhardt |
Depression and Anxiety | 2014 |
Phenotypic and molecular characteristics in eleven Chinese patients with 5α-reductase Type 2 deficiency
H Zhu, W Liu, B Han, M Fan, S Zhao, H Wang, Y Lu, C Pan, F Chen, M Chen, H Song, K Cheng, J Qiao |
Clinical Endocrinology | 2014 |
Pathways and genes involved in steroid hormone metabolism in male pigs: A review and update
A Robic, T Faraut, A Prunier |
The Journal of Steroid Biochemistry and Molecular Biology | 2014 |
Mechanisms of crosstalk between endocrine systems: Regulation of sex steroid hormone synthesis and action by thyroid hormones
P Duarte-Guterman, L Navarro-Martín, VL Trudeau |
General and Comparative Endocrinology | 2014 |
A population-based nested case-control study: the use of 5-alpha-reductase inhibitors and the increased risk of osteoporosis diagnosis in patients with benign prostate hyperplasia
WL Lin, YW Hsieh, CL Lin, FC Sung, CH Wu, CH Kao |
Clinical Endocrinology | 2014 |
5α-Reductase Type 1 Deficiency or Inhibition Predisposes to Insulin Resistance, Hepatic Steatosis, and Liver Fibrosis in Rodents
DE Livingstone, P Barat, EM di Rollo, GA Rees, BA Weldin, EA Rog-Zielinska, DP MacFarlane, BR Walker, R Andrew |
Diabetes | 2014 |
Steroidal pyrazolines and pyrazoles as potential 5α-reductase inhibitors: Synthesis and biological evaluation
AH Banday, SA Shameem, S Jeelani |
Steroids | 2014 |
Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis
SE Borst, JJ Shuster, B Zou, F Ye, H Jia, A Wokhlu, JF Yarrow |
BMC Medicine | 2014 |
The Impact of Exogenic Testosterone and Nortestosterone-Decanoate Toxicological Evaluation Using a Rat Model
RT Cristina, F Hanganu, E Dumitrescu, F Muselin, M Butnariu, A Constantin, V Chiurciu, B He |
PloS one | 2014 |
Effects of Unripe Black Raspberry Extracts on Prostate Cancer Cell Line and Rat Model of Benign Prostatic Hyperplasia
SJ Lee, HR Choi, JH Lee, JW Kwon, HK Lee, JT Jeong, TB Lee |
Journal of the Korean Society of Food Science and Nutrition | 2014 |
Expression levels of mRNA for neurosteroidogenic enzymes 17β-HSD, 5α-reductase, 3α-HSD and cytochrome P450 aromatase in the fetal wild type and SF-1 knockout mouse brain
T Spanic, T Fabjan, G Majdic |
Endocrine Research | 2014 |
Reference Module in Biomedical Sciences
DL Sackett, RB Haynes |
2014 | |
α-spinasterol from Melandrium firmum attenuates benign prostatic hyperplasia in a rat model
MY Lee, IS Shin, H Kyoung, CS Seo, JK Son, HK Shin |
Molecular medicine reports | 2014 |
Pathogenesis and Treatment of Acne and Rosacea
CC Zouboulis, AD Katsambas, AM Kligman |
2014 | |
Targeting cancer using cholesterol conjugates
AA Radwan, FK Alanazi |
Saudi Pharmaceutical Journal | 2013 |
Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer
FZ Stanczyk, CG Azen, MC Pike |
The Journal of Steroid Biochemistry and Molecular Biology | 2013 |
Of marsupials and men: “Backdoor” dihydrotestosterone synthesis in male sexual differentiation
A Biason-Lauber, WL Miller, AV Pandey, CE Flück |
Molecular and Cellular Endocrinology | 2013 |
Side Effects of 5-Alpha Reductase Inhibitors: A Comprehensive Review: 5ARI Side Effects
L Trost, TR Saitz, WJ Hellstrom |
Sexual Medicine Reviews | 2013 |
Inhibition of dehydroepiandosterone sulfate action in androgen-sensitive tissues by EM-1913, an inhibitor of steroid sulfatase
J Roy, J Lefebvre, R Maltais, D Poirier |
Molecular and Cellular Endocrinology | 2013 |
21-Hydroxylase deficiency in the neonate – Trends in steroid anabolism and catabolism during the first weeks of life
S Christakoudi, DA Cowan, G Christakudis, NF Taylor |
The Journal of Steroid Biochemistry and Molecular Biology | 2013 |
Metabolic considerations of drugs in the treatment of allergic diseases
E García-Martín, G Canto, JA Agúndez |
Expert Opinion on Drug Metabolism & Toxicology | 2013 |
Hair loss and herbs for treatment
N Lourith, M Kanlayavattanakul |
Journal of Cosmetic Dermatology | 2013 |
Sex dependent influence of a functional polymorphism in steroid 5-α-reductase type 2 (SRD5A2) on post-traumatic stress symptoms
CF Gillespie, LM Almli, AK Smith, B Bradley, K Kerley, DF Crain, KB Mercer, T Weiss, J Phifer, Y Tang, JF Cubells, EB Binder, KN Conneely, KJ Ressler |
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics | 2013 |
Metabolism of BYZX in Human Liver Microsomes and Cytosol: Identification of the Metabolites and Metabolic Pathways of BYZX
L Yu, Y Jiang, L Wang, R Sheng, Y Hu, S Zeng, C Holscher |
PloS one | 2013 |
Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes
J Li, E Mercer, X Gou, YJ Lu |
American journal of cancer research | 2013 |
Androgens and prostate disease
LA Cooper, ST Page |
Asian Journal of Andrology | 2013 |
Bisphenol A Modifies the Regulation Exerted by Testosterone on 5 α -Reductase Isozymes in Ventral Prostate of Adult Rats
P Sánchez, B Castro, JM Torres, A Olmo, RG Moral, E Ortega |
BioMed Research International | 2013 |
Dihydrotestosterone is elevated following sprint exercise in healthy young men
AA Smith, R Toone, O Peacock, S Drawer, KA Stokes, CJ Cook |
Journal of applied physiology | 2013 |
Clinical biochemistry of dihydrotestosterone
PM Marchetti, JH Barth |
Annals of Clinical Biochemistry | 2013 |
5-alpha-reductase type I (SRD5A1) is up-regulated in non-small cell lung cancer but does not impact proliferation, cell cycle distribution or apoptosis
FG Kapp, A Sommer, T Kiefer, G Dölken, B Haendler |
Cancer Cell International | 2012 |
Testosterone and Vascular Function in Aging
RA Lopes, KB Neves, FS Carneiro, RC Tostes |
Frontiers in physiology | 2012 |
Basal and Regulatory Promoter Studies of the AKR1C3 Gene in Relation to Prostate Cancer
JJ Schulze, H Karypidis, L Ekström |
Frontiers in pharmacology | 2012 |
Genome-Wide Association Study of d-Amphetamine Response in Healthy Volunteers Identifies Putative Associations, Including Cadherin 13 (CDH13)
AB Hart, BE Engelhardt, MC Wardle, G Sokoloff, M Stephens, H Wit, AA Palmer |
PloS one | 2012 |
Dutasteride monotherapy in men with serologic relapse following radical therapy for adenocarcinoma of the prostate: A pilot study
M Perrotti, R Jain, LM Abriel, TE Baroni, AB Corbett, SA Tenenbaum |
Urologic Oncology Seminars and Original Investigations | 2012 |
Expression of 5α-reductase in apocrine carcinoma of the breast and its correlation with clinicopathological aggressiveness : 5α-Reductase in apocrine carcinoma of the breast
S Kasashima, A Kawashima, S Ozaki, Y Nakanuma |
Histopathology | 2012 |
Promotion of Hair Growth by Rosmarinus officinalis Leaf Extract : HAIR GROWTH EFFECT OF Rosmarinus officinalis LEAF
K Murata, K Noguchi, M Kondo, M Onishi, N Watanabe, K Okamura, H Matsuda |
Phytotherapy Research | 2012 |
Campbell-Walsh Urology
I Singh, JW Strandhoy, DG Assimos |
Campbell-Walsh Urology | 2012 |
Cochrane Database of Systematic Reviews: Protocols
JJ Ho, AS Adnan, Z Darus, NZ Ismail, HV Rostenberghe, JJ Ho |
Cochrane Database of Systematic Reviews: Protocols | 2012 |
Association of V89L SRD5A2 polymorphism with craving and serum leptin levels in male alcohol addicts
B Lenz, E Schöpp, CP Müller, S Bleich, T Hillemacher, J Kornhuber |
Psychopharmacology | 2012 |
Regional distribution of 5α-reductase type 2 in the adult rat brain: An immunohistochemical analysis
MP Castelli, A Casti, A Casu, R Frau, M Bortolato, S Spiga, MG Ennas |
Psychoneuroendocrinology | 2012 |
Inhibiteurs des 5 alpha-réductases et cancer de la prostate : une mise au point du Comité de cancérologie de l’Association française d’urologie
P Eschwège, N Gaschignard, G Ploussard, M Peyromaure, C Bastide, L Cormier, P Mongiat-Artus, F Rozet, G Fromont, C Hennequin, R Renard-Penna, P Beuzeboc, P Richaud, M Soulié, L Salomon |
Progrès en Urologie | 2012 |
The activities of 5α-reductase and 17,20-lyase determine the direction through androgen synthesis pathways in patients with 21-hydroxylase deficiency
C Kamrath, MF Hartmann, T Remer, SA Wudy |
Steroids | 2012 |
The Basic Science of Hair Biology
T Breitkopf, G Leung, M Yu, E Wang, KJ McElwee |
Dermatologic Clinics | 2012 |
5α-Reductases in Human Physiology: An Unfolding Story
AM Traish |
Endocrine Practice | 2012 |
Adipocyte biology in polycystic ovary syndrome
TM Barber, S Franks |
Molecular and Cellular Endocrinology | 2012 |
Women with acute intermittent porphyria have a defect in 5α-steroid production during the menstrual cycle: Effects of porphyria on the menstrual cycle
E Innala, T Bäckström, IS Poromaa, C Andersson, M Bixo |
Acta Obstetricia et Gynecologica Scandinavica | 2012 |
Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
S Gur, PJ Kadowitz, WJ Hellstrom |
Expert Opinion on Drug Safety | 2012 |
Associations of serum sex steroid hormone and 5α-androstane-3α,17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasteride
AR Kristal, C Till, CM Tangen, PJ Goodman, ML Neuhouser, FZ Stanczyk, LW Chu, SK Patel, IM Thompson, JK Reichardt, A Hoque, EA Platz, WD Figg, AV Bokhoven, SM Lippman, AW Hsing |
Cancer epidemiology, biomarkers & prevention | 2012 |
The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
F Azzouni, A Godoy, Y Li, J Mohler |
Advances in Urology | 2012 |
Variants in the SRD5A2 gene are associated with quality of semen
D Zhao, W Wu, B Xu, X Niu, H Cui, YI ZHANG, Z Wang, X Wang |
Molecular medicine reports | 2012 |
Increased Activation of the Alternative “Backdoor” Pathway in Patients with 21-Hydroxylase Deficiency: Evidence from Urinary Steroid Hormone Analysis
C Kamrath, Z Hochberg, MF Hartmann, T Remer, SA Wudy |
The Journal of clinical endocrinology and metabolism | 2012 |
Intracrine and Myotrophic Roles of 5α-Reductase and Androgens: A Review
JF Yarrow, SC Mccoy, SE Borst |
Medicine and Science in Sports and Exercise | 2012 |
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
WL Miller, RJ Auchus |
Endocrine reviews | 2011 |
Potential prostate cancer drug target: Bioactivation of androstanediol by conversion to dihydrotestosterone
JL Mohler, MA Titus, EM Wilson |
Clinical cancer research | 2011 |
Estrogen and androgen signaling in the pathogenesis of BPH
CK Ho, FK Habib |
Nature Reviews Urology | 2011 |
Neurosteroid and GABA-A receptor alterations in Alzheimer's disease, Parkinson's disease and multiple sclerosis
S Luchetti, I Huitinga, DF Swaab |
Neuroscience | 2011 |
Synthesis and bioactivity of new Finasteride conjugate
Z Shuang, W Jiazhen, Y Lijuan, L Zhuo, Y Dahai, L Jinfeng, Y Jing, L Yongtao, W En-si, F Xuexun |
Bioorganic & Medicinal Chemistry Letters | 2011 |
Non polycystic ovary syndrome-related endocrine disorders associated with hirsutism
K Unluhizarci, G Kaltsas, F Kelestimur |
European Journal of Clinical Investigation | 2011 |
Neurosteroid biosynthetic pathways changes in prefrontal cortex in Alzheimer's disease
S Luchetti, K Bossers, SV de Bilt, V Agrapart, RR Morales, GV Frajese, DF Swaab |
Neurobiology of Aging | 2011 |
The Effects of 5α-Reductase Inhibition on Benign Prostatic Hyperplasia Treated by Photoselective Vaporization Prostatectomy with the 120 Watt GreenLight HPS Laser System
KH Strom, X Gu, M Spaliviero, C Wong |
Journal of the American College of Surgeons | 2011 |
The Critical Role of Androgens in Prostate Development
JD Wilson |
Endocrinology & Metabolism Clinics of North America | 2011 |
Molecular biology of androgen insensitivity
J Jääskeläinen |
Molecular and Cellular Endocrinology | 2011 |
Annual Reports in Medicinal Chemistry
JJ Liu, TW Lee |
Annual Reports in Medicinal Chemistry Volume 46 | 2011 |
A randomised, placebo-controlled trial of dutasteride in spinal and bulbar muscular atrophy
LE Fernández-Rhodes, AD Kokkinis, MJ White, CA Watts, S Auh, NO Jeffries, JA Shrader, TJ Lehky, L Li, JE Ryder, EW Levy, BI Solomon, MO Harris-Love, AL Pean, AB Schindler, C Chen, NA di Prospero, KH Fischbeck |
Lancet neurology | 2011 |
Hair Biology and Care Product Ingredients from Marine Organisms
SK Kim, SS Bak |
Marine Cosmeceuticals Trends and Prospects | 2011 |
5 -Reduced glucocorticoids: a story of natural selection
M Nixon, R Upreti, R Andrew |
Journal of Endocrinology | 2011 |
Williams Textbook of Endocrinology
DW Cooke, SA Divall, S Radovick |
Williams Textbook of Endocrinology | 2011 |
Increase in formalin-induced tonic pain by 5alpha-reductase and aromatase inhibition in female rats
M Moradi-Azani, A Ahmadiani, H Amini |
Pharmacology Biochemistry and Behavior | 2011 |
Dihydrotestosterone stimulates amino acid uptake and the expression of LAT2 in mouse skeletal muscle fibres through an ERK1/2-dependent mechanism: Amino acid uptake in mouse skeletal muscle fibres
MM Hamdi, G Mutungi |
The Journal of Physiology | 2011 |
Pilot Study of 15 Patients Receiving a New Treatment Regimen for Androgenic Alopecia: The Effects of Atopy on AGA
AW Rafi, RM Katz |
ISRN Dermatology | 2011 |
Synthesis and 5α-Reductase Inhibitory Activity of C21 Steroids Having 1,4-diene or 4,6-diene 20-ones and 4-Azasteroid 20-Oximes
S Kim, Y Kim, E Ma |
Molecules (Basel, Switzerland) | 2011 |
Handbook of Growth and Growth Monitoring in Health and Disease
VR Preedy |
2011 | |
Hormonal and Genetic Basis of Sexual Differentiation Disorders and Hot Topics in Endocrinology: Proceedings of the 2nd World Conference
MI New, JL Simpson |
2011 | |
Hormonal and Genetic Basis of Sexual Differentiation Disorders and Hot Topics in Endocrinology: Proceedings of the 2nd World Conference
MI New, JL Simpson |
2011 | |
Hormonal and Genetic Basis of Sexual Differentiation Disorders and Hot Topics in Endocrinology: Proceedings of the 2nd World Conference
MI New, JL Simpson |
2011 | |
Hormonal and Genetic Basis of Sexual Differentiation Disorders and Hot Topics in Endocrinology: Proceedings of the 2nd World Conference
MI New, JL Simpson |
2011 | |
Potential Prostate Cancer Drug Target: Bioactivation of Androstanediol by Conversion to Dihydrotestosterone: Figure 1
JL Mohler, MA Titus, EM Wilson |
Clinical cancer research | 2011 |
46,XY DSD due to impaired androgen production
BB Mendonca, EM Costa, A Belgorosky, MA Rivarola, S Domenice |
Best Practice & Research Clinical Endocrinology & Metabolism | 2010 |
Series in Cosmetic and Laser Therapy
NE Rogers, MR Avram |
Hair Transplantation | 2010 |
Biology and natural history of prostate cancer and the role of chemoprevention
MT Rosenberg, M Froehner, D Albala, MM Miner |
International Journal of Clinical Practice | 2010 |
Determination of rat 5α-reductase type 1 isozyme activity and its inhibition by novel steroidal oxazolines
M Szécsi, D Ondré, I Tóth, S Magony, J Wölfling, G Schneider, J Julesz |
Acta Biologica Hungarica | 2010 |
Androgen receptor and 5α-reductase immunohistochemical profiles in extramammary Paget disease
S Kasashima, S Ozaki, A Kawashima, Y Zen, T Moriya, M Inoue |
British Journal of Dermatology | 2010 |
5αDH-DOC (5α-dihydro-deoxycorticosterone) activates androgen receptor in castration-resistant prostate cancer
M Uemura, S Honma, S Chung, R Takata, M Furihata, K Nishimura, N Nonomura, Y Nasu, T Miki, T Shuin, T Fujioka, A Okuyama, Y Nakamura, H Nakagawa |
Cancer Science | 2010 |
Cloning and differential expression of steroid 5α-reductase type 1 (Srd5a1) and type 2 (Srd5a2) from the Harderian glands of hamsters
L Ramos, B Chávez, F Vilchis |
General and Comparative Endocrinology | 2010 |
Pathogenesis of Prostate Cancer
CY Yoon, SS Byun |
Journal of Korean Medical Association | 2010 |
Correlation between circulatory, local prostatic, and intra-prostatic androgen levels
M Olsson, L Ekström, C Guillemette, A Belanger, A Rane, O Gustafsson |
The Prostate | 2010 |
Establishment of a Novel Model for Studying the Effects of Extracts of Chinese Herb Medicine on Human Type II 5α-Reductase in Vitro
X WANG, J LIAO, D YIN, F ZHAN, S DAI, G XIE, X SANG |
YAKUGAKU ZASSHI | 2010 |
Undervirilization in XY newborns may hide a 5α-reductase deficiency: report of three new SRD5A2 gene mutations
L Maimoun, P Philibert, B Cammas, F Audran, C Pienkowski, F Kurtz, C Heinrich, M Cartigny, C Sultan |
International Journal of Andrology | 2010 |
Evolution of steroid-5α-reductases and comparison of their function with 5β-reductase
VS Langlois, D Zhang, GM Cooke, VL Trudeau |
General and Comparative Endocrinology | 2010 |
Self-organizing molecular field analysis on pregnane derivatives as human steroidal 5α-reductase inhibitors
S Aggarwal, S Thareja, TR Bhardwaj, M Kumar |
Steroids | 2010 |
Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: A randomized, double-blind, placebo-controlled, phase III study
HC Eun, OS Kwon, JH Yeon, HS Shin, BY Kim, BI Ro, HK Cho, WY Sim, BL Lew, WS Lee, HY Park, SP Hong, JH Ji |
Journal of the American Academy of Dermatology | 2010 |
Vitamins & Hormones
KJ Hare, FK Knop |
Vitamins & Hormones | 2010 |
Benign Prostatic Hyperplasia
DR Paolone |
Clinics in Geriatric Medicine | 2010 |
Dihydrotestosterone activates the MAPK pathway and modulates maximum isometric force through the EGF receptor in isolated intact mouse skeletal muscle fibres: Acute effects of DHT in isolated intact mouse skeletal muscle fibres
MM Hamdi, G Mutungi |
The Journal of Physiology | 2010 |
Clinical, hormonal, and molecular-genetic characteristics of three cases of 46XY disorder of sex development caused by type II 5-alpha reductase deficiency
AA Kolodkina, ME Karmanov, NI Kalinchenko, AN Nizhnik, MA Nokel', AK Faĭzulin, AN Tiul'pakov |
Problems of Endocrinology | 2010 |
3D-QSAR studies on unsaturated 4-azasteroids as human 5α-reductase inhibitors: A self organizing molecular field analysis approach
S Aggarwal, S Thareja, TR Bhardwaj, M Kumar |
European Journal of Medicinal Chemistry | 2010 |
Expanding the Use of Fluorogenic Enzyme Reporter Substrates to Imaging Metabolic Flux Changes: the Activity Measurement of 5α-Steroid Reductase in Intact Mammalian Cells
PC Rodriguez, DJ Yee, D Sames |
ACS chemical biology | 2010 |
Drug Management of Prostate Cancer
WD Figg, CH Chau, EJ Small |
2010 | |
Limb Muscles Are Androgen Targets in an Acrobatic Tropical Bird
NY Feng, A Katz, LB Day, J Barske, BA Schlinger |
Endocrinology | 2010 |
5αDH‐DOC (5α‐dihydro‐deoxycorticosterone) activates androgen receptor in castration‐resistant prostate cancer
Uemura M, Honma S, Chung S, Takata R, Furihata M, Nishimura K, Nonomura N, Nasu Y, Miki T, Shuin T, Fujioka T, Okuyama A, Nakamura Y, Nakagawa H |
Cancer Science | 2010 |
Doping in Sports
D Thieme, P Hemmersbach |
2009 | |
Doping in Sports
D Thieme, P Hemmersbach |
2009 | |
Doping in Sports
D Thieme, P Hemmersbach |
2009 | |
Basic and Clinical Dermatology
N Muizzuddin, D Maes, P Giacomoni |
Skin Moisturization | 2009 |
Yen & Jaffe's Reproductive Endocrinology
RA Lobo |
Yen & Jaffe's Reproductive Endocrinology | 2009 |
Changes in human placental 5α-reductase isoenzyme expression with advancing gestation: effects of fetal sex and glucocorticoid exposure
TT Vu, JJ Hirst, M Stark, IM Wright, HK Palliser, N Hodyl, VL Clifton |
Reproduction, Fertility and Development | 2009 |
5α-Reductase Isozymes and Androgen Actions in the Prostate
YS Zhu, JL Imperato-McGinley |
Annals of the New York Academy of Sciences | 2009 |
Radical prostatectomy: Influence on serum and urinary androgen levels
M Olsson, L Ekström, J Schulze, A Kjellman, O Akre, A Rane, O Gustafsson |
The Prostate | 2009 |
Neurosteroid biosynthesis: Enzymatic pathways and neuroendocrine regulation by neurotransmitters and neuropeptides
JL Rego, JY Seong, D Burel, J Leprince, V Luu-The, K Tsutsui, MC Tonon, G Pelletier, H Vaudry |
Frontiers in Neuroendocrinology | 2009 |
Overexpression of 5α-reductase type 1 increases sensitivity of prostate cancer cells to low concentrations of testosterone
LN Thomas, RC Douglas, RS Rittmaster, CK Too |
The Prostate | 2009 |
Genetic Analysis of the SRD5A2 Gene in Indian Patients with 5α-Reductase Deficiency
R Sahu, R Boddula, P Sharma, V Bhatia, R Greaves, S Rao, M Desai, A Wakhlu, S Phadke, M Shukla, P Dabadghao, RN Mehrotra, E Bhatia |
Journal of Pediatric Endocrinology and Metabolism | 2009 |
Key targets of hormonal treatment of prostate cancer. Part 2: the androgen receptor and 5α-reductase
AN Vis, FH Schröder |
BJU International | 2009 |
Serum LH correlates highly with intratesticular steroid levels in normal men
MY Roth, K Lin, JK Amory, AM Matsumoto, BD Anawalt, CN Snyder, TF Kalhorn, WJ Bremner, ST Page |
Journal of andrology | 2009 |
Understanding the Epidemiology, Natural History, and Key Pathways Involved in Prostate Cancer
ED Crawford |
Urology | 2009 |
Yen & Jaffe's Reproductive Endocrinology
SF Thung, ER Norwitz |
Yen & Jaffe's Reproductive Endocrinology | 2009 |
Hormones, Brain and Behavior
J Bernal |
Hormones, Brain and Behavior | 2009 |
Genetic variation in androgen disposition: implications in clinical medicine including testosterone abuse
JJ Schulze, A Rane, L Ekström |
Expert Opinion on Drug Metabolism & Toxicology | 2009 |
Cosmetics Applications of Laser & Light-Based Systems
VA Randall, NV Botchkareva |
Cosmetics Applications of Laser & Light-Based Systems | 2009 |
Synthesis of Pregnane Derivatives, Their Cytotoxicity on LNCap and PC-3 Cells, and Screening on 5α-Reductase Inhibitory Activity
S Kim, E Ma |
Molecules (Basel, Switzerland) | 2009 |
Androgen Action in Prostate Cancer
J Mohler, D Tindall |
2009 | |
Prostate Cancer Screening
DP Ankerst, CM Tangen, IM Thompson |
2009 | |
Androgen synthesis in adrenarche
WL Miller |
Reviews in Endocrine and Metabolic Disorders | 2008 |
Pharmacology of anabolic steroids
AT Kicman |
British Journal of Pharmacology | 2008 |
The Effect of 5α-Reductase Inhibition With Dutasteride and Finasteride on Bone Mineral Density, Serum Lipoproteins, Hemoglobin, Prostate Specific Antigen and Sexual Function in Healthy Young Men
JK Amory, BD Anawalt, AM Matsumoto, ST Page, WJ Bremner, C Wang, RS Swerdloff, RV Clark |
The Journal of Urology | 2008 |
Molecular diagnosis of 5α-reductase-2 gene mutation in two Indian families with male pseudohermaphroditism
M Eunice, P Philibert, B Kulshreshtha, F Audran, F Paris, ML Khurana, PE Pulikkanath, K Kucheria, C Sultan, AC Ammini |
Asian Journal of Andrology | 2008 |
Gender Identity of Children and Young Adults with 5α-Reductase Deficiency
EP Praveen, AK Desai, ML Khurana, J Philip, M Eunice, R Khadgawat, B Kulshreshtha, K Kucheria, DK Gupta, A Seith, AC Ammini |
Journal of Pediatric Endocrinology and Metabolism | 2008 |
Shorter CAG repeats in androgen receptor and non-GG genotypes in prostate-specific antigen loci are associated with decreased risk of benign prostatic hyperplasia and prostate cancer
K Das, PY Cheah, PL Lim, YB Zain, FC Stephanie, Y Zhao, C Cheng, W Lau |
Cancer Letters | 2008 |
Androgen deprivation therapy for precancerous lesions of the prostate
D Hull, DG Bostwick |
Best Practice & Research Clinical Endocrinology & Metabolism | 2008 |
5-Alpha Reductase Inhibitors and Erectile Dysfunction: The Connection
F Erdemir, A Harbin, WJ Hellstrom |
Journal of Sexual Medicine | 2008 |
Type 1 and Type 2 5α-Reductase Expression in the Development and Progression of Prostate Cancer
LN Thomas, RC Douglas, CB Lazier, CK Too, RS Rittmaster, DJ Tindall |
European Urology | 2008 |
Androgen biosynthetic pathways in the human prostate
V Luu-The, A Bélanger, F Labrie |
Best Practice & Research Clinical Endocrinology & Metabolism | 2008 |
A potential paradox in prostate adenocarcinoma progression: Oestrogen as the initiating driver
PB Singh, SS Matanhelia, FL Martin |
European Journal of Cancer | 2008 |
5-alpha-reductase and the development of the human prostate
C Radmayr, A Lunacek, C Schwentner, J Oswald, H Klocker, G Bartsch |
Indian journal of urology : IJU : journal of the Urological Society of India | 2008 |
The Adrenal Cortex and Its Disorders
WL Miller, JC Achermann, CE Flück |
Pediatric Endocrinology | 2008 |
Medical treatments for male and female pattern hair loss
NE Rogers, MR Avram |
Journal of the American Academy of Dermatology | 2008 |
Évolution de la cellule normale à la cellule cancéreuse prostatique hormonodépendante–hormono-indépendante
PM Martin, X Muracciole, C Berenguer, F Boudouresque, LH Ouafik |
Médecine Nucléaire | 2008 |
Polymorphisms of steroid 5- α- reductase type I (SRD5A1) gene are associated to peripheral arterial disease
SS Signorelli, V Barresi, N Musso, M Anzaldi, E Croce, V Fiore, DF Condorelli |
Journal of Endocrinological Investigation | 2008 |
The effect of finasteride on spermatogenesis of Mesocricetus auratus
DJ Vidigal, AL da Silva, LM da Fonseca, AC Vasconcelos, DF de Resende, FE Vidigal |
Acta Cirurgica Brasileira | 2008 |
Testosterone and DHEA activate the glucose metabolism-related signaling pathway in skeletal muscle
K Sato, M Iemitsu, K Aizawa, R Ajisaka |
American journal of physiology. Endocrinology and metabolism | 2008 |
Hair Growth and Disorders
U Blume-Peytavi, A Tosti, RM Trüeb |
2008 | |
Dermatologic Manifestations of Polycystic Ovary Syndrome
AT Lee, LT Zane |
American Journal of Clinical Dermatology | 2007 |
Novel 5α-steroid reductase (SRD5A3, type-3) is overexpressed in hormone-refractory prostate cancer
M Uemura, K Tamura, S Chung, S Honma, A Okuyama, Y Nakamura, H Nakagawa |
Cancer Science | 2007 |
Finasteride to Evaluate the Efficacy of Dutasteride in the Management of Patients with Lower Urinary Tract Symptoms and Enlarged Prostate
IR Ravish, RB Nerli, SS Amarkhed |
Systems Biology in Reproductive Medicine | 2007 |
Oxytocin increases 5α-reductase activity of human prostate epithelial cells, but not stromal cells
SJ Assinder |
The Prostate | 2007 |
Medical treatment of benign prostatic hyperplasia
SS Connolly, JM Fitzpatrick |
Postgraduate medical journal | 2007 |
Outcomes and quality of life issues in the pharmacological management of benign prostatic hyperplasia (BPH)
AJ Cambio, CP Evans |
Therapeutics and Clinical Risk Management | 2007 |
Establishment of type II 5α-reductase over-expressing cell line as an inhibitor screening model
S Jang, Y Lee, SL Hwang, MH Lee, SJ Park, IH Lee, S Kang, SS Roh, YJ Seo, JK Park, JH Lee, CD Kim |
The Journal of Steroid Biochemistry and Molecular Biology | 2007 |
Fetal Distribution of 5α-Reductase 1 and 5α-Reductase 2, and Their Input on Human Prostate Development
A Lunacek, C Schwentner, J Oswald, H Fritsch, C Sergi, LN Thomas, RS Rittmaster, H Klocker, H Neuwirt, G Bartsch, C Radmayr |
The Journal of Urology | 2007 |
Effects of various pesticides on human 5α-reductase activity in prostate and LNCaP cells
S Lo, I King, A Alléra, D Klingmüller |
Toxicology in Vitro | 2007 |
Handbook of Neurochemistry and Molecular Neurobiology
VH Routh, JJ McArdle, NM Sanders, Z Song, R Wang |
Handbook of Neurochemistry and Molecular Neurobiology | 2007 |
Effect of finasteride 5 mg (Proscar) on acne and alopecia in female patients with normal serum levels of free testosterone
C Kohler, K Tschumi, C Bodmer, M Schneiter, M Birkhaeuser |
Gynecological Endocrinology | 2007 |
The Leydig Cell in Health and Disease
AH Payne, MP Hardy |
2007 | |
The Effect of 5α-Reductase Inhibition with Dutasteride and Finasteride on Semen Parameters and Serum Hormones in Healthy Men
JK Amory, C Wang, RS Swerdloff, BD Anawalt, AM Matsumoto, WJ Bremner, SE Walker, LJ Haberer, RV Clark |
The Journal of clinical endocrinology and metabolism | 2007 |
Androgen Excess Disorders in Women
R Azziz, JE Nestler, D Dewailly |
2007 | |
Uroonkologie
H Rübben |
2007 | |
Novel 5α‐steroid reductase (SRD5A3, type‐3) is overexpressed in hormone‐refractory prostate cancer
Uemura M, Tamura K, Chung S, Honma S, Okuyama A, Nakamura Y, Nakagawa H |
Cancer Science | 2007 |
Persistent intraprostatic androgen concentrations after medical castration in healthy men
ST Page, DW Lin, EA Mostaghel, DL Hess, LD True, JK Amory, PS Nelson, AM Matsumoto, WJ Bremner |
The Journal of clinical endocrinology and metabolism | 2006 |
Pharmacokinetics and Pharmacodynamics of Nonsteroidal Androgen Receptor Ligands
W Gao, J Kim, JT Dalton |
Pharmaceutical Research | 2006 |
Tissue-specific transcription profiles of sex steroid biosynthesis enzymes and the androgen receptor
U Hoppe, PM Holterhus, L Wünsch, D Jocham, T Drechsler, S Thiele, C Marschke, O Hiort |
Journal of Molecular Medicine | 2006 |
A New Look at the 5?-Reductase Inhibitor Finasteride
DA Finn, AS Beadles-Bohling, EH Beckley, MM Ford, KR Gililland, RE Gorin-Meyer, KM Wiren |
CNS Drug Reviews | 2006 |
Common genetic polymorphisms and prognosis of sporadic cancers: prostate cancer as a model
T Habuchi |
Future Oncology | 2006 |
Regulation of prostate 5α-reductase-2 gene expression and prostate weight by dietary fat and caloric intake in the rat
LQ Cai, J Imperato-McGinley, YS Zhu |
The Prostate | 2006 |
Prevention of Benign Prostatic Hyperplasia Disease
LS Marks, CG Roehrborn, GL Andriole |
The Journal of Urology | 2006 |
Finasteride as a chemopreventive agent in prostate cancer: impact of the PCPT on urologic practice
MA Goetzl, JM Holzbeierlein |
Nature Clinical Practice Urology | 2006 |
5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
VM Hayes, G Severi, EJ Padilla, HA Morris, WD Tilley, MC Southey, DR English, RL Sutherland, JL Hopper, P Boyle, GG Giles |
International Journal of Cancer | 2006 |
The role of dutasteride in the treatment of benign prostatic obstruction and related conditions
K Davenport, P Abrams |
Aging Health | 2006 |
Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis
RC Agís-Balboa, G Pinna, A Zhubi, E Maloku, M Veldic, E Costa, A Guidotti |
Proceedings of the National Academy of Sciences | 2006 |
A Critical Analysis of Permixon™ in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Enlargement
C Maccagnano, A Salonia, A Briganti, P Teillac, C Schulman, F Montorsi, P Rigatti |
European Urology Supplements | 2006 |
5α-Reductase Inhibitors and Chemoprevention: The PCPT and Beyond
G Andriole |
European Urology Supplements | 2006 |
Genetic Instabilities and Neurological Diseases
R Krahe, LL Bachinski, B Udd |
Genetic Instabilities and Neurological Diseases | 2006 |
Principles of Molecular Medicine
MS Runge, C Patterson |
2006 | |
PTSD
N Kato, M Kawata, RK Pitman |
2006 | |
Chemistry and Structural Biology of Androgen Receptor
W Gao, CE Bohl, JT Dalton |
Chemical Reviews | 2005 |
Androgenic correlates of genetic variation in the gene encoding 5α-reductase type 1
JA Ellis, S Panagiotopoulos, A Akdeniz, G Jerums, SB Harrap |
Journal of Human Genetics | 2005 |
Folia Pharmacologica Japonica
Y Ohsugi, N Tsuchimoto |
Folia Pharmacologica Japonica | 2005 |
Topography and function of androgen-metabolizing enzymes in the central nervous system
Y Tsuruo |
Anatomical Science International | 2005 |
Population Pharmacokinetic–Pharmacodynamic Modeling of TF-505 Using Extension of Indirect Response Model by Incorporating a Circadian Rhythm in Healthy Volunteers
Y Matsumoto, T Fujita, Y Ishida, M Shimizu, H Kakuo, K Yamashita, M Majima, Y Kumagai |
Biological & Pharmaceutical Bulletin | 2005 |
Dutasteride: a novel dual inhibitor of 5α-reductase for benign prostatic hyperplasia
B Djavan, S Milani, YK Fong |
Expert Opinion on Pharmacotherapy | 2005 |
Localization of 5α-reductase in the rat main olfactory bulb
E Kiyokage, K Toida, T Suzuki-Yamamoto, K Ishimura |
The Journal of Comparative Neurology | 2005 |
Sexual dimorphism of growth plate prehypertrophic and hypertrophic chondrocytes in response to testosterone requires metabolism to dihydrotestosterone (DHT) by steroid 5-alpha reductase type 1
P Raz, E Nasatzky, BD Boyan, A Ornoy, Z Schwartz |
Journal of Cellular Biochemistry | 2005 |
The 5α-Reductase Type II A49T and V89L High-Activity Allelic Variants are More Common in Men with Prostate Cancer Compared with the General Population
YL Giwercman, PA Abrahamsson, A Giwercman, V Gadaleanu, G Ahlgren |
European Urology | 2005 |
Molecular Basis of Steroid Action in the Prostate
YS Zhu |
Cellscience | 2005 |
5α-Reductase Isozymes in the Prostate
YS Zhu, GH Sun |
Journal of medical sciences (Taipei, Taiwan) | 2005 |
Dutasteride: a review of current data on a novel dual inhibitor of 5alpha reductase
S Marihart, M Harik, B Djavan |
Reviews in urology | 2005 |
In vivo evidence for an increase in 5alpha-reductase activity in the rat central nervous system following morphine exposure
H Amini, A Ahmadiani |
International Journal of Developmental Neuroscience | 2005 |
International Review of Neurobiology
ZT Bloomgarden |
International review of neurobiology | 2005 |
Pediatric Endocrinology
PS Thornton |
Pediatric Endocrinology | 2005 |
Cloning and Characterization of the 5α-Reductase Type 2 Promoter in the Rat Epididymis1
S Seenundun, B Robaire |
Biology of reproduction | 2005 |
Prevention of Hormone-Related Cancers: Prostate Cancer
HL Parnes, IM Thompson, LG Ford |
Journal of Clinical Oncology | 2005 |
Deficiência de 5alfa-redutase tipo 2: experiências de Campinas (SP) e Salvador (BA)
C Hackel, LE de Oliveira, MB Toralles, D Nunes-Silva, MM Tonini, LF Ferraz, L Steinmetz, D Damiani, LC de Oliveira, AT Maciel-Guerra, EG Stuchi-Perez, G Guerra-Júnior |
Arquivos brasileiros de endocrinologia e metabologia | 2005 |
Chemoprevention using dutasteride: the REDUCE trial:
LG Gomella |
Current Opinion in Urology | 2005 |
5?-reductase in human embryonic kidney cell line HEK293: Evidence for type II enzyme expression and activity
BU Panter, J Jose, RW Hartmann |
Molecular and Cellular Biochemistry | 2005 |
Hormonal Carcinogenesis IV
JJ Li, SA Li, A Llombart-Bosch |
2005 | |
Oral Testosterone in Oil Plus Dutasteride in Men: A Pharmacokinetic Study
JK Amory, WJ Bremner |
The Journal of clinical endocrinology and metabolism | 2005 |
Cochrane Database of Systematic Reviews
L Hooper, C Bartlett, GD Smith, S Ebrahim, L Hooper |
Cochrane Database of Systematic Reviews | 2004 |
Rooster feathering, androgenic alopecia, and hormone-dependent tumor growth: What is in common?
JA Mayer, CM Chuong, R Widelitz |
Differentiation | 2004 |
Agents in development for prostate cancer prevention
WG Nelson |
Expert Opinion on Investigational Drugs | 2004 |
Patients with a large prostate show a higher prevalence of androgenetic alopecia
WC Chen, CC Yang, GY Chen, MC Wu, HM Sheu, TS Tzai |
Archives of Dermatological Research | 2004 |
Messenger RNA levels and enzyme activities of 5 alpha-reductase types 1 and 2 in human benign prostatic hyperplasia (BPH) tissue
T Shirakawa, H Okada, B Acharya, Z Zhang, N Hinata, Y Wada, T Uji, S Kamidono, A Gotoh |
The Prostate | 2004 |
Phase I and clinical pharmacology of a type I and II, 5-alpha-reductase inhibitor (LY320236) in prostate cancer: elevation of estradiol as possible mechanism of action
MA Eisenberger, M Laufer, NJ Vogelzang, O Sartor, D Thornton, BL Neubauer, V Sinibaldi, G Lieskovsky, MA Carducci, M Zahurak, D Raghavan |
Urology | 2004 |
Anomalies de la différenciation sexuelle
F Kuttenn, MF d'Acremont, I Mowszowicz |
EMC - Endocrinologie - Nutrition | 2004 |
Ketocazole as an adjunct to finasteride in the treatment of androgenetic alopecia in men
BS Perez |
Medical Hypotheses | 2004 |
Selective non-steroidal inhibitors of 5α-reductase type 1
EG Occhiato, A Guarna, G Danza, M Serio |
The Journal of Steroid Biochemistry and Molecular Biology | 2004 |
Medical Treatment of BPH: An Update on Results
RE Power, JM Fitzpatrick |
EAU Update Series | 2004 |
Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma
MJ Lewis, JP Wiebe, JG Heathcote |
BMC Cancer | 2004 |
Comparison of the Pharmacological Effects of a Novel Selective Androgen Receptor Modulator, the 5α-Reductase Inhibitor Finasteride, and the Antiandrogen Hydroxyflutamide in Intact Rats: New Approach for Benign Prostate Hyperplasia
W Gao, JD Kearbey, VA Nair, K Chung, AF Parlow, DD Miller, JT Dalton |
Endocrinology | 2004 |
A systemic type i 5 α-reductase inhibitor is ineffective in the treatment of acne vulgaris
J Leyden, W Bergfeld, L Drake, F Dunlap, MP Goldman, AB Gottlieb, MP Heffernan, JG Hickman, M Hordinsky, M Jarrett, S Kang, A Lucky, G Peck, T Phillips, M Rapaport, J Roberts, R Savin, ME Sawaya, A Shalita, J Shavin, JC Shaw, L Stein, D Stewart, J Strauss, J Swinehart, L Swinyer, D Thiboutot, K Washenik, G Weinstein, D Whiting, F Pappas, M Sanchez, L Terranella, J Waldstreicher |
Journal of the American Academy of Dermatology | 2004 |
Chemotherapeutic Prevention Studies of Prostate Cancer
B Djavan, A Zlotta, C Schulman, P Teillac, P IVERSEN, LB Gibod, G Bartsch, M Marberger |
The Journal of Urology | 2004 |
CHEMOPREVENTION OF PROSTATE CANCER IN MEN AT HIGH RISK: RATIONALE AND DESIGN OF THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) TRIAL
G Andriole, D Bostwick, O Brawley, L Gomella, M Marberger, D Tindall, S Breed, M SOMERVILLE, R Rittmaster |
The Journal of Urology | 2004 |
Serum Androgen Bioactivity in Adolescence: A Longitudinal Study of Boys with Constitutional Delay of Puberty
T Raivio, L Dunkel, S Wickman, OA Jänne |
The Journal of clinical endocrinology and metabolism | 2004 |
Hypospadias and Genital Development
LS Baskin |
2004 | |
Regulation of 5α-Reductase Isoforms by Oxytocin in the Rat Ventral Prostate
SJ Assinder, C Johnson, K King, HD Nicholson |
Endocrinology | 2004 |
Chemopr�vention des Prostatakarzinoms
B Djavan, I Thompson, MS Michel, M Waldert, C Seitz |
Der Urologe, Ausgabe A | 2004 |
Genetic polymorphisms and prostate cancer risk
A Gsur, E Feik, S Madersbacher |
World Journal of Urology | 2004 |
Neurosteroid Biosynthesis in the Human Brain and Its Clinical Implications
B Stoffel-Wagner |
Annals of the New York Academy of Sciences | 2003 |
5 Alpha-reductase inhibitors: whatʼs new?
CL Foley, RS Kirby |
Current Opinion in Urology | 2003 |
Molecular epidemiology of hypospadias: Review of genetic and environmental risk factors
JM Manson, MC Carr |
Birth Defects Research Part A: Clinical and Molecular Teratology | 2003 |
Analysis of genetic polymorphisms of steroid 5α-reductase type 1 and 2 genes in Korean men with androgenetic alopecia
SJ Ha, JS Kim, JW Myung, HJ Lee, JW Kim |
Journal of Dermatological Science | 2003 |
Genetic polymorphisms of steroid hormone metabolizing enzymes and risk of liver cancer in hepatitis C-infected patients
L Rossi, M Leveri, C Gritti, AD Silvestri, C Zavaglia, L Sonzogni, L Silvestri, E Civardi, MU Mondelli, EM Silini |
Journal of Hepatology | 2003 |
5α-Reductase Type 1 Immunostaining is Enhanced in Some Prostate Cancers Compared With Benign Prostatic Hyperplasia Epithelium
L Thomas, R Douglas, J Vessey, R Gupta, D Fontaine, R Norman, I Thompson, D Troyer, R Rittmaster, C Lazier |
The Journal of Urology | 2003 |
Characterization and modulation of sex steroid metabolizing activity in normal human keratinocytes in primary culture and HaCaT cells
S Gingras, C Turgeon, N Brochu, P Soucy, F Labrie, J Simard |
The Journal of Steroid Biochemistry and Molecular Biology | 2003 |
Prostate Cancer
WG Nelson, AM de Marzo, WB Isaacs |
New England Journal of Medicine | 2003 |
Comparative pharmacophore development for inhibitors of human and rat 5-α-reductase
J Faragalla, J Bremner, D Brown, R Griffith, A Heaton |
Journal of Molecular Graphics and Modelling | 2003 |
Frontiers in Neuroscience: The Role of the GABA-A Receptor
S Mellon |
Frontiers in neuroscience | 2003 |
Testosterone replacement therapy in male hypogonadism
MM Byrne, E Nieschlag |
Journal of Endocrinological Investigation | 2003 |
Nuclear Receptors
B Belandia, MG Parker |
Cell | 2003 |
Activity and expression of progesterone metabolizing 5α-reductase, 20α-hydroxysteroid oxidoreductase and 3α(β)-hydroxysteroid oxidoreductases in tumorigenic (MCF-7, MDA-MB-231, T-47D) and nontumorigenic (MCF-10A) human breast cancer cells
JP Wiebe, MJ Lewis |
BMC Cancer | 2003 |
Androgen-Induced Prostate-Specific Antigen Gene Expression Is Mediated via Dihydrotestosterone in LNCaP Cells
YS Zhu, LQ Cai, X You, JJ Cordero, Y Huang, J Imperato-McGinley |
Journal of andrology | 2003 |
5α-Reductase Isoenzymes 1 and 2 in the Rat Testis During Postnatal Development1
J Killian, K Pratis, RJ Clifton, PG Stanton, DM Robertson, L O'Donnell |
Biology of reproduction | 2003 |
Development of a quantitative RT-PCR method to study 5?-reductase mRNA isozymes in rat prostate in different androgen status
JM Torres, E Ruiz, E Ortega |
The Prostate | 2003 |
Decreased gene expression of steroid 5 alpha-reductase 2 in human prostate cancer: Implications for finasteride therapy of prostate carcinoma
J Luo, TA Dunn, CM Ewing, PC Walsh, WB Isaacs |
The Prostate | 2003 |
Androgens in Health and Disease
CJ Bagatell, WJ Bremner |
2003 | |
New Evidence of Similarity between Human and Plant Steroid Metabolism: 5α-Reductase Activity in Solanum malacoxylon
F Rosati, G Danza, A Guarna, N Cini, ML Racchi, M Serio |
Endocrinology | 2003 |
Estimating the Contribution of the Prostate to Blood Dihydrotestosterone
AW Toorians, S Kelleher, LJ Gooren, M Jimenez, DJ Handelsman |
The Journal of clinical endocrinology and metabolism | 2003 |
Semiquantitative RT-PCR method coupled to capillary electrophoresis to study 5alpha-reductase mRNA isozymes in rat ventral prostate in different androgen status
Jesus M Torres, José A Gómez-Capilla, Estrella Ruiz, Esperanza Ortega |
Molecular and Cellular Biochemistry | 2003 |
Stable maintenance of 5alpha-reductase activity in long-term subcultures of fibroblasts derived from the foreskin
K Nakae, M Tsuji, T Kuraoka, S Cho, GR Cunha, H Shima |
International Journal of Urology | 2002 |
Androgens and male physiology the syndrome of 5α-reductase-2 deficiency
J Imperato-McGinley, YS Zhu |
Molecular and Cellular Endocrinology | 2002 |
The genetics of male undermasculinization
SF Ahmed, IA Hughes |
Clinical Endocrinology | 2002 |
Advances in male contraception
BM Brady, RA Anderson |
Expert Opinion on Investigational Drugs | 2002 |
A novel homozygous disruptive mutation in the SRD5A2-gene in a partially virilized patient with 5alpha-reductase deficiency
O Hiort, SM Schutt, M Bals-Pratsch, PM Holterhus, C Marschke, D Struve |
International Journal of Andrology | 2002 |
Androgens and alopecia
KD Kaufman |
Molecular and Cellular Endocrinology | 2002 |
Hormonal treatment for male-pattern hair loss: implications for cancer of the prostate?
WR Anderson, NM Harris, SA Holmes |
BJU International | 2002 |
Pharmacokinetics and pharmacodynamics of TF-505, a novel nonsteroidal 5alpha-reductase inhibitor, in normal subjects treated with single or multiple doses
T Fujita, Y Matsumoto, T Kimura, S Yokota, M Sawada, M Majima, Y Ohtani, Y Kumagai |
British Journal of Clinical Pharmacology | 2002 |
Expression of androgen receptor and 5?-reductases in the human normal endometrium and its disorders
K Ito, T Suzuki, J Akahira, T Moriya, C Kaneko, H Utsunomiya, N Yaegashi, K Okamura, H Sasano |
International Journal of Cancer | 2002 |
Inhibition of type 1 and type 2 5α-reductase activity by free fatty acids, active ingredients of Permixon®
JP Raynaud, H Cousse, PM Martin |
The Journal of Steroid Biochemistry and Molecular Biology | 2002 |
Evidence that steroid 5α-reductase isozyme genes are differentially methylated in human lymphocytes
M Rodrı́guez-Dorantes, M Lizano-Soberón, I Camacho-Arroyo, R Calzada-León, S Morimoto, N Téllez-Ascencio, MA Cerbón |
The Journal of Steroid Biochemistry and Molecular Biology | 2002 |
Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia
CG Roehrborn, P Boyle, JC Nickel, K Hoefner, G Andriole |
Urology | 2002 |
Nonsteroidal compounds designed to mimic potent steroid sulfatase inhibitors
LC Ciobanu, V Luu-The, D Poirier |
The Journal of Steroid Biochemistry and Molecular Biology | 2002 |
Structure–activity relationships for inhibition of human 5α-reductases by polyphenols
RA Hiipakka, HZ Zhang, W Dai, Q Dai, S Liao |
Biochemical Pharmacology | 2002 |
Acne and hirsutism in polycystic ovary syndrome: clinical, endocrine–metabolic and ultrasonographic differences
L Falsetti, A Gambera, S Andrico, E Sartori |
Gynecological Endocrinology | 2002 |
Early growth, adult body size and prostate cancer risk
GG Giles, G Severi, DR English, MR McCredie, R MacInnis, P Boyle, JL Hopper |
International Journal of Cancer | 2002 |
Pediatric Gender Assignment
SA Zderic, DA Canning, MC Carr, HM Snyder |
2002 | |
Integration of Pharmaceutical Discovery and Development
RT Borchardt, RM Freidinger, TK Sawyer, PL Smith |
2002 | |
Male Contraception
RA Anderson, DT Baird |
Endocrine reviews | 2002 |
Androgens and Androgen Receptor
C Chang |
2002 | |
Expression of 5alpha-Reductases in Human Epithelial Ovarian Cancer: Its Correlation with Androgen Receptor Status
JI Akahira, T Suzuki, K Ito, RD Darnel, T Moriya, S Sato, N Yaegashi, K Okamura, H Sasano |
Cancer Science | 2001 |
Developmental aspects of androgen action
IA Hughes, HN Lim, H Martin, NP Mongan, L Dovey, SF Ahmed, JR Hawkins |
Molecular and Cellular Endocrinology | 2001 |
5α-Reductase Inhibitors in the Treatment of Androgenetic Alopecia
KD Kaufman |
International Journal of Cosmetic Surgery and Aesthetic Dermatology | 2001 |
The genetics of androgenetic alopecia
JA Ellis, SB Harrap |
Clinics in Dermatology | 2001 |
Androgenetic alopecia in men and women
RD Sinclair, RP Dawber |
Clinics in Dermatology | 2001 |
Down-regulation of intestinal scavenger receptor class B, type I (SR-BI) expression in rodents under conditions of deficient bile delivery to the intestine
PJ Voshol, M Schwarz, A Rigotti, M Krieger, AK Groen, F Kuipers |
Biochemical Journal | 2001 |
5α-reductase inhibitors: what role should they play?
SA Kaplan |
Urology | 2001 |
A novel class of inhibitors for steroid 5α-Reductase: synthesis and evaluation of umbelliferone derivatives
G Fan, W Mar, MK Park, EW Choi, K Kim, S Kim |
Bioorganic & Medicinal Chemistry Letters | 2001 |
Clinical application of 5α-reductase inhibitors
A Cilotti, G Danza, M Serio |
Journal of Endocrinological Investigation | 2001 |
Effect of estrogen replacement therapy on distribution of myocardial blood flow in female anesthetized rabbits
JR Rouleau, A Dagnault, D Simard, B Lavallée, A Bélanger, A Blouin, JG Kingma |
American journal of physiology. Heart and circulatory physiology | 2001 |
Linear Relationships between the Ligand Binding Energy and the Activation Energy of Time-dependent Inhibition of Steroid 5α-Reductase by Δ 1 -4-Azasteroids
G Tian, CD Haffner |
The Journal of biological chemistry | 2001 |
Regulation of Uterine 5α-Reductase Type 1 in Mice1
D Minjarez, V Konda, RA Word |
Biology of reproduction | 2001 |
Minireview: Sex Differentiation
IA Hughes |
Endocrinology | 2001 |
Phenotypic Variation in a Family with Partial Androgen Insensitivity Syndrome Explained by Differences in 5α Dihydrotestosterone Availability
AL Boehmer, AO Brinkmann, RM Nijman, MC Verleun-Mooijman, P de Ruiter, MF Niermeijer, SL Drop |
The Journal of clinical endocrinology and metabolism | 2001 |
Expression of 5α‐Reductases in Human Epithelial Ovarian Cancer: Its Correlation with Androgen Receptor Status
Akahira J, Suzuki T, Ito K, Darnel RD, Moriya T, Sato S, Yaegashi N, Okamura K, Sasano H |
Japanese journal of cancer research : Gann | 2001 |
Partial sequencing and tissue distribution of the canine isoforms of steroid 5?-Reductase type I and type II
PN Span, A Bokhoven, AG Smals, CG Sweep, JA Schalken |
The Prostate | 2000 |
Neurosteroids: Biosynthesis and Function of These Novel Neuromodulators
NA Compagnone, SH Mellon |
Frontiers in Neuroendocrinology | 2000 |
The effects of diet on circulating sex hormone levels in men
NE Allen, TJ Key |
Nutrition Research Reviews | 2000 |
Nishi Nihon Hifuka
E MORITA |
Nishi Nihon Hifuka | 2000 |
Regional Differences of Pheromone Production in the Sebaceous Glands of Castrated Goats Treated with Testosterone
Y WAKABAYASHI, E IWATA, T KIKUSUI, Y TAKEUCHI, Y MORI |
Journal of Veterinary Medical Science | 2000 |
Male pattern hair loss: prevention rather than regrowth
M Ramos-e-Silva |
International Journal of Dermatology | 2000 |
Evaluation of the Tubular and Interstitial Functions of the Testis in 46,XY Patients with Ambiguous Genitalia
EG Stuchi-Perez, C Lukas-Croisier, MD Castro, MT Baptista, MR Scolfaro, AP Marques-De-Faria, C Hackel |
Journal of Pediatric Endocrinology and Metabolism | 2000 |
SAW PALMETTO FOR THE TREATMENT OF MEN WITH LOWER URINARY TRACT SYMPTOMS
GS Gerber |
The Journal of Urology | 2000 |
Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia
VH Price, JL Roberts, M Hordinsky, EA Olsen, R Savin, W Bergfeld, V Fiedler, A Lucky, DA Whiting, F Pappas, J Culbertson, P Kotey, A Meehan, J Waldstreicher |
Journal of the American Academy of Dermatology | 2000 |
Hair and Its Disorders: Biology, Pathology and Management
V Randall |
Hair and Its Disorders: Biology, Pathology and Management | 2000 |
Kinetic analysis of LY320236: competitive inhibitor of type I and non-competitive inhibitor of type II human steroid 5α-reductase
AM McNulty, JE Audia, KG Bemis, RL Goode, VP Rocco, BL Neubauer |
The Journal of Steroid Biochemistry and Molecular Biology | 2000 |
Hormônio anti-mülleriano: revisão e contribuição para a investigação das ambigüidades genitais
EG Perez, GG Júnior |
Arquivos brasileiros de endocrinologia e metabologia | 2000 |
Terapia della calvizie e dell’irsutismo con inibitori della 5α-riduttasi
A Cilotti, G Danza, M Serio |
L'Endocrinologo | 2000 |
Role of Hormones in Pilosebaceous Unit Development
D Deplewski, RL Rosenfield |
Endocrine reviews | 2000 |
Idiopathic Hirsutism*
R Azziz, E Carmina, ME Sawaya |
Endocrine reviews | 2000 |
Finasteride, a Type 2 5α-reductase inhibitor, in the treatment of men with androgenetic alopecia
KD Kaufman, RP Dawber |
Expert Opinion on Investigational Drugs | 1999 |
Improvement in androgenetic alopecia in 53-76-year-old men using oral finasteride
S Brenner, H Matz |
International Journal of Dermatology | 1999 |
SELECTIVITY OF FINASTERIDE AS AN IN VIVO INHIBITOR OF 5 alpha-REDUCTASE ISOZYME ENZYMATIC ACTIVITY IN THE HUMAN PROSTATE
PN Span, MC Voller, AG Smals, FG Sweep, JA Schalken, MR Feneley, RS Kirby |
The Journal of Urology | 1999 |
Comparison of finasteride and flutamide in the treatment of idiopathic hirsutism
L Falsetti, A Gambera |
Fertility and Sterility | 1999 |
Acquired scalp alopecia. Part II: A review
JR Sullivan, S Kossard |
Australasian Journal of Dermatology | 1999 |
New frameshift mutation in the 5?-reductase type 2 gene in a Brazilian patient with 5?-reductase deficiency
LF Ferraz, MT Baptista, AT Maciel-Guerra, GG J�nior, C Hackel |
American Journal of Medical Genetics | 1999 |
5?-reductase isozymes and aromatase are differentially expressed and active in the androgen-independent human prostate cancer cell lines DU145 and PC3
P Negri-Cesi, A Colciago, A Poletti, M Motta |
The Prostate | 1999 |
5 alpha-REDUCTASE TYPE 2 MUTATIONS ARE PRESENT IN SOME BOYS WITH ISOLATED HYPOSPADIAS
RI Silver, DW Russell |
The Journal of Urology | 1999 |
5 α-REDUCTASE TYPE 2 MUTATIONS ARE PRESENT IN SOME BOYS WITH ISOLATED HYPOSPADIAS
RI Silver, DW Russell |
The Journal of Urology | 1999 |
Racial differences in the androgen/androgen receptor pathway in prostate cancer
CA Pettaway |
Journal of the National Medical Association | 1999 |
Differences in steroid 5α-reductase iso-enzymes expression between normal and pathological human prostate tissue
C Iehlé, F Radvanyi, SG de Medina, LH Ouafik, H Gérard, D Chopin, JP Raynaud, PM Martin |
The Journal of Steroid Biochemistry and Molecular Biology | 1999 |
The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia
L Drake, M Hordinsky, V Fiedler, J Swinehart, WP Unger, PC Cotterill, DM Thiboutot, N Lowe, C Jacobson, D Whiting, S Stieglitz, SJ Kraus, EI Griffin, D Weiss, P Carrington, C Gencheff, GW Cole, DM Pariser, ES Epstein, W Tanaka, A Dallob, K Vandormael, L Geissler, J Waldsteicher |
Journal of the American Academy of Dermatology | 1999 |
Clinical dose ranging studies with finasteride, a type 2 5α-reductase inhibitor, in men with male pattern hair loss
JL Roberts, V Fiedler, J Imperato-McGinley, D Whiting, E Olsen, J Shupack, D Stough, R DeVillez, R Rietschel, R Savin, W Bergfeld, J Swinehart, T Funicella, M Hordinsky, N Lowe, I Katz, A Lucky, L Drake, VH Price, D Weiss, E Whitmore, L Millikan, S Muller, C Gencheff, P Carrington, B Binkowitz, P Kotey, W He, K Bruno, C Jacobsen, L Terranella, GJ Gormley, KD Kaufman |
Journal of the American Academy of Dermatology | 1999 |
G-protein-coupled, extracellular Ca(2+)-sensing receptor: a versatile regulator of diverse cellular functions
J Fox, MA Miller, GB Stroup, EF Nemeth, SC Miller |
Vitamins and hormones | 1999 |
ANDROGEN METABOLISM AS IT AFFECTS HAIR GROWTH IN ANDROGENETIC ALOPECIA
KD Kaufman |
Dermatologic Clinics | 1999 |
The Role of Androgens in Male Gender Role Behavior
JD Wilson |
Endocrine reviews | 1999 |
5α-Reductase Activity in Women with Polycystic Ovary Syndrome1
AJ Jakimiuk, SR Weitsman, DA Magoffin |
The Journal of clinical endocrinology and metabolism | 1999 |
Neurosteroids
EE Baulieu, P Robel, M Schumacher |
1999 | |
7α-Methyl-19-Nortestosterone Maintains Sexual Behavior and Mood in Hypogonadal Men*
RA Anderson, CW Martin, AW Kung, D Everington, TC Pun, KC Tan, J Bancroft, K Sundaram, AJ Moo-Young, DT Baird |
The Journal of clinical endocrinology and metabolism | 1999 |
Finasteride: A Review of its Use in Male Pattern Hair Loss
KJ McClellan, A Markham |
Drugs | 1999 |
Molecular medicine of steroid hormone biosynthesis
A Biason-Lauber |
Molecular Aspects of Medicine | 1998 |
Effects of long-term treatment withSerenoa repens (Permixon®) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia
FD Silverio, S Monti, A Sciarra, PA Varasano, C Martini, S Lanzara, G D'Eramo, SD Nicola, V Toscano |
The Prostate | 1998 |
Pharmacokinetics and pharmacodynamics of FK143, a nonsteroidal inhibitor of steroid 5α-reductase, in healthy volunteers
M Katashima, T Irino, F Shimojo, A Kawamura, H Kageyama, N Higashi, Y Miyao, Y Tokuma, T Hata, K Yamamoto, Y Sawada, T Iga |
Clinical Pharmacology & Therapeutics | 1998 |
5α-Reductase Isozymes in the Central Nervous System
A Poletti, A Coscarella, P Negri-Cesi, A Colciago, F Celotti, L Martini |
Steroids | 1998 |
Finasteride in the treatment of men with androgenetic alopecia
KD Kaufman, EA Olsen, D Whiting, R Savin, R DeVillez, W Bergfeld, VH Price, DV Neste, JL Roberts, M Hordinsky, J Shapiro, B Binkowitz, GJ Gormley |
Journal of the American Academy of Dermatology | 1998 |
Regional Distribution of 5α-Reductase Type 1 and Type 2 mRNA Along the Human Epididymis
MC Mahony, DJ Swanlund, M Billeter, KP Roberts, JL Pryor |
Fertility and Sterility | 1998 |
Genetic Analysis of Male Pattern Baldness and the 5alpha-Reductase Genes
JA Ellis, M Stebbing, SB Harrap |
Journal of Investigative Dermatology | 1998 |
Predominance of type I 5alpha-reductase in apocrine sweat glands of patients with excessive or abnormal odour derived from apocrine sweat (osmidrosis)
Sato, Sonoda, Itami, Takayasu |
British Journal of Dermatology | 1998 |
LOCALIZATION BY IN SITU HYBRIDIZATION OF STEROID 5 alpha-REDUCTASE ISOZYME GENE EXPRESSION IN THE HUMAN PROSTATE AND PREPUTIAL SKIN
G Pelletier, V Luu-The, XF Huang, H Lapointe, F Labrie |
The Journal of Urology | 1998 |
Presence of 5α-Reductase isozymes and aromatase in human prostate cancer cells and in benign prostate hyperplastic tissue
P Negri-Cesi, A Poletti, A Colciago, P Magni, P Martini, M Motta |
The Prostate | 1998 |
5α-reductase and 17β-hydroxysteroid dehydrogenase expression in epithelial cells from hyperplastic and malignant human prostate
S Délos, JL Carsol, F Fina, JP Raynaud, PM Martin |
International Journal of Cancer | 1998 |
Erectile dysfunction following treatments of benign prostatic hyperplasia: A prospective study
MC Uygur, E Gür, AI Arik, U Altuǧ, D Erol |
Andrologia | 1998 |
Endocrine and adrenergic pharmacological intervention in diseases of the prostate
A Rane |
British Journal of Clinical Pharmacology | 1998 |
Effects of the 5α-Reductase Inhibitor Finasteride on Serum Levels of Gonadal, Adrenal, and Hypophyseal Hormones and its Clinical Significance: A Prospective Clinical Study
MC Uygur, Aİ Arık, U Altuğ, D Erol |
Steroids | 1998 |
PNU 157706, a novel dual type I and II5α-reductase inhibitor
E Salle, D Giudici, A Radice, T Zaccheo, G Ornati, M Nesi, A Panzeri, S Délos, PM Martin |
The Journal of Steroid Biochemistry and Molecular Biology | 1998 |
Association of Benign Prostatic Hyperplasia with Male Pattern Baldness
BR Oh, SJ Kim, JD Moon, HN Kim, DD Kwon, YH Won, SB Ryu, YI Park |
Urology | 1998 |
Advances in Protein Chemistry
CM Silva, J Isgaard, MO Thorner |
Advances in Protein Chemistry | 1998 |
DISORDERS OF SEXUAL DIFFERENTIATION
GL Warne, JD Zajac |
Endocrinology and metabolism clinics of North America | 1998 |
Proscar@ (Finasteride) inhibits 5α-reductase activity in the ovaries and testes of Lytechinus variegatus Lamarck (Echinodermata: Echinoidea)
KM Wasson, SA Watts |
Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology | 1998 |
Natural potent androgens: Lessons from human genetic models
Y Zhu, MD Katz, J Imperato-McGinley |
Baillière's Clinical Endocrinology and Metabolism | 1998 |
Effect of finasteride in idiopathic hirsutism
E Faloia, S Filipponi, V Mancini, SD Marco, F Mantero |
Journal of Endocrinological Investigation | 1998 |
Evidence of Heterogeneity and Quantitative Differences of the Type 1 5α-Reductase Expression in Cultured Human Skin Cells – Evidence of its Presence in Melanocytes
W Chen, CC Zouboulis, M Fritsch, U Blume-Peytavi, V Kodelja, S Goerdt, V Luu-The, CE Orfanos |
Journal of Investigative Dermatology | 1998 |
cDNA Cloning of Mouse and Human Cholesterol 25-Hydroxylases, Polytopic Membrane Proteins That Synthesize a Potent Oxysterol Regulator of Lipid Metabolism
EG Lund, TA Kerr, J Sakai, WP Li, DW Russell |
The Journal of biological chemistry | 1998 |
Endocrinology of Pregnancy
FW Bazer |
1998 | |
Molecular Basis of Sex Hormone Receptor Function
H Gronemeyer, U Fuhrmann, K Parczyk |
1998 | |
Luteinizing Hormone and Human Chorionic Gonadotropin Decrease Type 2 5α-Reductase and Androgen Receptor Protein Levels in Women’s Skin
J Bird, X Li, ZM Lei, J Sanfilippo, MA Yussman, CV Rao |
The Journal of clinical endocrinology and metabolism | 1998 |
Marked reduction in bile acid synthesis in cholesterol 7α-hydroxylase-deficient mice does not lead to diminished tissue cholesterol turnover or to hypercholesterolemia
M Schwarz, DW Russell, JM Dietschy, SD Turley |
Journal of lipid research | 1998 |
Expression of 5α-Reductase in the Human Temporal Lobe of Children and Adults1
B Stoffel-Wagner, M Watzka, S Steckelbroeck, L Wickert, J Schramm, G Romalo, D Klingmüller, HU Schweikert |
The Journal of clinical endocrinology and metabolism | 1998 |
Inhibitory Effects of Serenoa repens on the Kinetic of Pig Prostatic Microsomal 5α-Reductase Activity
MF Palin, M Faguy, JG LeHoux, G Pelletier |
Endocrine | 1998 |
Topical finasteride in the treatment of androgenic alopecia. Preliminary evaluations after a 16-month therapy course
GF Mazzarella, GF Loconsole, GA Cammisa, GM Mastrolonardo, G Vena |
Journal of Dermatological Treatment | 1997 |
Activity of type 1 5α–reductase is greater in the follicular infrainfundibulum compared with the epidermis
D Thiboutot, H Knaggs, K Gilliland, S Hagari |
British Journal of Dermatology | 1997 |
Effects of finasteride, a type 2 5-alpha reductase inhibitor, on fetal development in the rhesus monkey (Macaca mulatta)
S Prahalada, AF Tarantal, GS Harris, KP Ellsworth, AP Clarke, GL Skiles, KI MacKenzie, LF Kruk, DS Ablin, MA Cukierski, CP Peter, MJ vanZwieten, AG Hendrickx |
Teratology | 1997 |
Different Levels of 5alpha-Reductase Type I and II, Aromatase, and Androgen Receptor in Hair Follicles of Women and Men with Androgenetic Alopecia
ME Sawaya, VH Price |
Journal of Investigative Dermatology | 1997 |
Pharmacological and molecular evidence for the expression of the two steroid 5α-reductase isozymes in normal and hyperplastic human prostatic cells in culture
I Berthaut, C Mestayer, MC Portois, O Cussenot, I Mowszowicz |
The Prostate | 1997 |
Steroid 5α-reductase inhibitors in androgen-dependent disorders
GS Harris, JW Kozarich |
Current Opinion in Chemical Biology | 1997 |
Identification of two novel cis-elements in the promoter of the prostate-specific antigen gene that are required to enhance androgen receptor-mediated transactivation
J Zhang, S Zhang, PE Murtha, W Zhu, SS Hou, CY Young |
Nucleic Acids Research | 1997 |
Steroid Metabolism in the Mammalian Brain: 5Alpha-Reduction and Aromatization
F Celotti, P Negri-Cesi, A Poletti |
Brain Research Bulletin | 1997 |
Inhibition of rat α-reductases by finasteride: Evidence for isozyme differences in the mechanism of inhibition
B Azzolina, K Ellsworth, S Andersson, W Geissler, HG Bull, GS Harris |
The Journal of Steroid Biochemistry and Molecular Biology | 1997 |
Male pseudohermaphroditism due to 5 alpha-reductase-2 deficiency in an Arab kindred
HM al-Attia |
Postgraduate medical journal | 1997 |
Male Infertility and Sexual Dysfunction
WJ Hellstrom |
1997 | |
Preputial Sebocyte 5α-Reductase Isoform Specificity*
D Deplewski, S Liao, RL Rosenfield |
Endocrinology | 1997 |
Activity of type 1 5α-reductase is greater in the follicular infrainfundibulum compared with the epidermis
D Thiboutot, H Knaggs, K Gilliland, S Hagari |
British Journal of Dermatology | 1997 |
Differential Gene Expression of Steroid 5α-Reductase 2 in Core Needle Biopsies from Malignant and Benign Prostatic Tissue1
C Bjelfman, TG Söderström, E Brekkan, BJ Norlén, L Egevad, T Unge, S Andersson, A Rane |
The Journal of clinical endocrinology and metabolism | 1997 |
Benign Prostatic Hyperplasia: Practical Treatment Guidelines
T Tammela |
Drugs & Aging | 1997 |
Role of dihydrotestosterone in androgen action
JD Wilson |
The Prostate | 1996 |
Male Pseudohermaphroditism Due to Steroid 5 alpha-Reductase 2 Deficiency
BB Mendonca, M Inacio, EM Costa, IJ Arnhold, FA Silva, W Nicolau, W Bloise, DW Russell, JD Wilson |
Medicine | 1996 |
Immunohistochemical Analysis of Steroid 5?-Reductase Type 1 in Human Scalp and Prostate
S Patel, M Einstein, W Geissler, L Wu, S Andersson |
Annals of the New York Academy of Sciences | 1996 |
The development of non-steroidal dual inhibitors of both human 5α-reductase isozymes
J Blagg, SA Ballard, K Cooper, PW Finn, PS Johnson, F MacIntyre, GN Maw, PL Spargo |
Bioorganic & Medicinal Chemistry Letters | 1996 |
Responses of LNCaP prostatic adenocarcinoma cell cultures to LY300502, a benzoquinolinone human type I 5α-reductase inhibitor
DM Sutkowski, JE Audia, RL Goode, KC Hsiao, IY Leibovitch, AM McNulty, BL Neubauer |
The Prostate | 1996 |
ANTIANDROGEN THERAPY IN DERMATOLOGY
JC Shaw |
International Journal of Dermatology | 1996 |
Synthesis of 4,17-diazasteroid inhibitors of human 5α-reductase
JW Morzycki, Z z.xl;Lotowski, AZ Wilczewska, JD Stuart |
Bioorganic & Medicinal Chemistry | 1996 |
Immunochemical detection of 5α-reductase in human serum
ME Lombardo, PB Hudson |
Steroids | 1996 |
Kinetic analysis of rat steroid 5α-reductase activity in prostate and epididymis homogenates at neutral pH: Evidence for type I activity in epididymis
PN Span, TJ Benraad, CG Sweep, AG Smals |
The Journal of Steroid Biochemistry and Molecular Biology | 1996 |
Kinetic analysis of steroid 5α-reductase activity at neutral pH in benign prostatic hyperplastic tissue: Evidence for type I isozyme activity in the human prostate
PN Span, TJ Benraad, CG Sweep, AG Smals |
The Journal of Steroid Biochemistry and Molecular Biology | 1996 |
Characterization of 5α-reductase gene expression in stroma and epithelium of human prostate
N Bruchovsky, MD Sadar, K Akakura, SL Goldenberg, K Matsuoka, PS Rennie |
The Journal of Steroid Biochemistry and Molecular Biology | 1996 |
FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
D Giudici, G Briatico, C Cominato, T Zaccheo, C Iehlè, M Nesi, A Panzeri, E Salle |
The Journal of Steroid Biochemistry and Molecular Biology | 1996 |
Characterization of type I 5α-reductase activity in DU145 human prostatic adenocarcinoma cells
M Kaefer, JE Audia, N Bruchovsky, RL Goode, KC Hsiao, IY Leibovitch, JH Krushinski, C Lee, CP Steidle, DM Sutkowski, BL Neubauer |
The Journal of Steroid Biochemistry and Molecular Biology | 1996 |
MK386: a potent, selective inhibitor of the human type 1 5α-reductase
K Ellsworth, B Azzolina, W Baginsky, H Bull, B Chang, G Cimis, S Mitra, J Toney, RK Bakshi, GR Rasmusson, RL Tolman, GS Harris |
The Journal of Steroid Biochemistry and Molecular Biology | 1996 |
Acne
GF Webster |
Current Problems in Dermatology | 1996 |
ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
JC Shaw |
Dermatologic Clinics | 1996 |
Metabolism of steroids in the brain: a new insight into the role of 5α-reductase and aromatase in brain differentiation and functions
P Negri-Cesi, A Poletti, F Celotti |
The Journal of Steroid Biochemistry and Molecular Biology | 1996 |
In Vivo Time-Dependent Inhibition of Human Steroid 5a-Reductase by Finasteride
G Tian |
Journal of Pharmaceutical Sciences | 1996 |
Finasteride**Proscar; Merck, Sharp, and Dohme, Rahway, New Jersey. in the treatment of hirsutism: new therapeutic perspectives
A Tolino, A Petrone, F Sarnacchiaro, D Cirillo, S Ronsini, G Lombardi, C Nappi |
Fertility and Sterility | 1996 |
Outcome of long-term treatment with the 5α-reductase inhibitor finasteride in idiopathic hirsutism: clinical and hormonal effects during a 1-year course of therapy and 1-year follow-up**Supported by grants from the Consiglio Nazionale delle Ricerche (INV 963687) and the Italian Ministry of Higher Education and Scientific Research
R Castello, F Tosi, F Perrone, C Negri, M Muggeo, P Moghetti |
Fertility and Sterility | 1996 |
5α-Reductases and Their Inhibitors
G Spera, C Lubrano |
International journal of immunopathology and pharmacology | 1996 |
Testosterone metabolism in primary cultures of epithelial cells and stroma from benign prostatic hyperplasia
M Tsugaya, FK Habib, GD Chisholm, M Ross, K Tozawa, Y Hayashi, K Kohri, S Tanaka |
Urological Research | 1996 |
Carcinoma of the Prostate
Z Petrovich, L Baert, LW Brady |
1996 | |
Serenoa repens (Permixon®): A Review of its Pharmacology and Therapeutic Efficacy in Benign Prostatic Hyperplasia
GL Plosker, RN Brogden |
Drugs & Aging | 1996 |
Activity of the Type 1 5alpha-Reductase Exhibits Regional Differences in Isolated Sebaceous Glands and Whole Skin
D Thiboutot, G Harris, V Iles, G Cimis, K Gilliland, S Hagari |
Journal of Investigative Dermatology | 1995 |
Disorders of sexual development
JD Zajac, GL Warne |
Baillière's Clinical Endocrinology and Metabolism | 1995 |
Cations Inhibit Specifically Type I 5alpha-Reductase Found in Human Skin
Y Sugimoto, I Lopez-Solache, F Labrie, V Luu-The |
Journal of Investigative Dermatology | 1995 |
Activin and inhibin have opposite effects on steroid 5α-reductase activity in genital skin fibroblasts
I Antonipillai, M Wahe, J Yamamoto, R Horton |
Molecular and Cellular Endocrinology | 1995 |
Human fetal adrenal hydroxysteroid sulphotransferase: cDNA cloning, stable expression in V79 cells and functional characterisation of the expressed enzyme
KJ Forbes, M Hagen, H Glatt, R Hume, MW Coughtrie |
Molecular and Cellular Endocrinology | 1995 |
The enzyme and inhibitors of 4-ene-3-oxosteroid 5α-oxidoreductase
X Li, C Chen, SM Singh, F Labire |
Steroids | 1995 |
Cloning, expression and functional characterization of type 1 and type 2 steroid 5α-reductases from Cynomolgus monkey: Comparisons with human and rat isoenzymes
MA Levy, M Brandt, KM Sheedy, DA Holt, JI Heaslip, JJ Trill, PJ Ryan, RA Morris, LM Garrison, DJ Bergsma |
The Journal of Steroid Biochemistry and Molecular Biology | 1995 |
Testosterone metabolism in primary cultures of human prostate epithelial cells and fibroblasts
S De´los, JL Carsol, E Ghazarossian, JP Raynaud, PM Martin |
The Journal of Steroid Biochemistry and Molecular Biology | 1995 |
Rat steroid 5α-reductase kinetic characteristics: Extreme pH-dependency of the type II isozyme in prostate and epididymis homogenates
PN Span, AG Smals, CG Sweep, TJ Benraad |
The Journal of Steroid Biochemistry and Molecular Biology | 1995 |
FK143, a novel nonsteroidal inhibitor of steroid 5α-reductase: (1) In vitro effects on human and animal prostatic enzymes
J Hirosumi, O Nakayama, T Fagan, K Sawada, N Chida, M Inami, S Takahashi, H Kojo, Y Notsu, M Okuhara |
The Journal of Steroid Biochemistry and Molecular Biology | 1995 |
Human prostatic steroid 5α-reductase isoforms—A comparative study of selective inhibitors
C Iehlé, S Délos, O Guirou, R Tate, JP Raynaud, PM Martin |
The Journal of Steroid Biochemistry and Molecular Biology | 1995 |
Synthesis of 6-azacholesten-3-ones: Potent inhibitors of 5α-reductase
C Haffner |
Tetrahedron Letters | 1995 |
Androgenetic alopecia: An autosomal dominant disorder
WF Bergfeld |
The American Journal of Medicine | 1995 |
Role of androgens in the developmental biology of the pilosebaceous unit
RL Rosenfield, D Deplewski |
The American Journal of Medicine | 1995 |
Benign prostatic hyperplasia
WD Steers, B Zorn |
Disease-a-Month | 1995 |
BENIGN PROSTATIC HYPERPLASIA
JD McConnell |
The Urologic clinics of North America | 1995 |
5α-Reductase inhibitors and prostatic disease
FH Schröder |
Clinical Endocrinology | 1994 |
Male pseudohermaphroditism caused by mutations of testicular 17β–hydroxysteroid dehydrogenase 3
WM Geissler, DL Davis, L Wu, KD Bradshaw, S Patel, BB Mendonca, KO Elliston, JD Wilson, DW Russell, S Andersson |
Nature Genetics | 1994 |
5α-Réductases: Physiologie et pathologie
I Mowszowicz, I Berthaut, C Mestayer, F Wright, F Kuttenn, P Mauvais-Jarvis |
Andrologie | 1994 |
Purification of testosterone 5∝-reductase from human prostate by a four-step chromatographic procedure
E Quemener, Y Amet, S Stefano, G Fournier, HH Floch, JH Abalain |
Steroids | 1994 |
Finasteride
AJ Wood, RS Rittmaster |
New England Journal of Medicine | 1994 |
9 Role of 5α-reductase in health and disease
VA Randall |
Baillière's Clinical Endocrinology and Metabolism | 1994 |
Pretranslational down-regulation of male specific hepatic P450s after portal bypass
J Xing-Mai, E Cantrill, GC Farrell, M Murray |
Biochemical Pharmacology | 1994 |
17.beta.-(N-tert-Butylcarbamoyl)-4-aza-5.alpha.-androstan-1-en-3-one Is an Active Site-Directed Slow Time-Dependent Inhibitor of Human Steroid 5.alpha.-Reductase 1
G Tian, JD Stuart, ML Moss, PL Domanico, HN Bramson, IR Patel, SH Kadwell, LK Overton, TA Kost |
Biochemistry | 1994 |
Expression and Regulation of Steroid 5α-Reductase 2 in Prostate Disease
RI Silver, EL Wiley, DL Davis, AE Thigpen, DW Russell, JD Mcconnell |
The Journal of Urology | 1994 |
Endocrine Evaluation of Testicular Function
SJ Winters |
Endocrinology and metabolism clinics of North America | 1994 |
International Review of Cytology
RA Miller |
International Review of Cytology | 1991 |